{
  "meta": {
    "title": "00377_Late_Night_Pyq_Inicet_Mixed_Bag-5",
    "url": "https://brainandscalpel.vercel.app/00377-late-night-pyq-inicet-mixed-bag-5-961c83c6.html",
    "scrapedAt": "2025-11-29T18:10:45.422Z"
  },
  "questions": [
    {
      "id": 4903,
      "choices": [
        {
          "id": 19587,
          "text": "<p><span style=\"font-size:12.0pt;\">Mismatch repair</span></p>"
        },
        {
          "id": 19588,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleotide excision repair</span></p>"
        },
        {
          "id": 19589,
          "text": "<p><span style=\"font-size:12.0pt;\">Base excision repair</span></p>"
        },
        {
          "id": 19590,
          "text": "<p><span style=\"font-size:12.0pt;\">Homologous recombinant repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient who is a diagnosed case of HNPCC, which of the following is the most common repair associated with it? (</span>NEET PG 2021)</p>",
      "unique_key": "Q4576543",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136807,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mismatch repair</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mismatch Repair (MMR) defect leads to Hereditary Non-Polyposis Colorectal Cancer (HNPCC). This mechanism corrects errors that typically occur during DNA replication. Mutations in MMR genes result in microsatellite instability and contribute to the development of various cancers at an early age. In contrast, Homologous Repair (HR) defects are associated with other genetic disorders and cancers, including Bloom syndrome, Werner syndrome, breast cancer, and Ataxia-Telangiectasia like disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nucleotide excision repair:&nbsp;</strong>Incorrect for this context as it deals with the repair of bulky helix-distorting lesions caused by UV radiation and chemicals, leading to diseases like Xeroderma pigmentosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Base excision repair:&nbsp;</strong>Incorrect as it fixes small non-helix-distorting bases caused by spontaneous or induced changes, leading to conditions like MUTYH-associated polyposis when defective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Homologous recombinant repair:&nbsp;</strong>Incorrect for HNPCC. It repairs double-strand breaks or interstrand cross-links in DNA, not typically involved in the pathogenesis of HNPCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-175723.jpg\" alt=\"\" width=\"1000\" height=\"403\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>- Harper 31<sup>st</sup> e/pg. 370</strong></span></p>",
      "correct_choice_id": 19587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7012,
      "choices": [
        {
          "id": 28016,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endothelium independent coronary vasodilation</span></span></span></p>"
        },
        {
          "id": 28017,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced cardiac contractility</span></span></span></p>"
        },
        {
          "id": 28018,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased left ventricular end diastolic volume</span></span></span></p>"
        },
        {
          "id": 28019,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased diastolic perfusion pressure</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with Prinzmetal angina is administered isosorbide mononitrate and is noticed to have symptomatic relief. What is the mechanism of action of nitrate in this case? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3504325",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137461,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Endothelium independent coronary vasodilation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nitrates cause endothelium-independent coronary vasodilation when treating Prinzmetal angina.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coronary artery vasospasm is the underlying cause of Prinzmetal angina. By relaxing the smooth muscles of the epicardial coronary arteries, nitrates treat coronary artery spasm.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main mechanism of action of nitrates in the event of stable angina is preferred vein dilation (by increasing cGMP). Venous return to the heart is reduced as a result of venous dilatation (preload). Due to the reduction in ventricular end-diastolic volume, myocardial oxygen consumption also reduces.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced cardiac contractility</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not the primary mechanism of action of nitrates in relieving Prinzmetal angina. Nitrates primarily work by vasodilation rather than affecting myocardial contractility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased left ventricular end diastolic volume</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nitrates generally reduce the preload (venous return) by dilating veins, which can lead to a decrease in left ventricular end-diastolic volume, not an increase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased diastolic perfusion pressure</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While nitrates can lower blood pressure, the primary therapeutic effect in Prinzmetal angina is not related to diastolic perfusion pressure but to the direct vasodilation of the coronary arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitrates provide symptomatic relief in Prinzmetal angina through endothelium-independent coronary vasodilation, which helps to alleviate coronary artery spasms and restore proper blood flow to the heart muscle.</span></span></p>",
      "correct_choice_id": 28016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4937,
      "choices": [
        {
          "id": 19722,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparan sulphate&nbsp;</span></p>"
        },
        {
          "id": 19723,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratan sulphate</span></p>"
        },
        {
          "id": 19724,
          "text": "<p><span style=\"font-size:12.0pt;\">Chondroitin sulphate</span></p>"
        },
        {
          "id": 19725,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyaluronic acid</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Transparency of corneal endothelium is maintained by:&nbsp;(NEET PG 2021)</span></p>",
      "unique_key": "Q9674645",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136813,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Keratan sulphate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Keratan sulfate is a key glycosaminoglycan present in the corneal endothelium. It plays a significant role in maintaining corneal transparency by regulating hydration, contributing to the structural integrity of the cornea, and preventing swelling, which could impair vision.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heparan sulfate</strong>: Heparan sulfate is a glycosaminoglycan (GAG) found in the cornea, but its main role is in the basement membrane and Bowman's membrane, rather than the corneal endothelium. It plays a role in supporting the structure but is not the primary factor for endothelial transparency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chondroitin sulfate</strong>: Chondroitin sulfate is another glycosaminoglycan found in the cornea, but its primary role is not related to endothelial transparency. It contributes to the overall structure and function of the cornea but does not play a direct role in maintaining endothelial clarity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyaluronic acid</strong>: Hyaluronic acid is essential for regulating hydration within the cornea, but its main role is in the corneal stroma, not the endothelium. It ensures the cornea remains transparent by preventing excessive swelling in the stromal tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-181532.jpg\" alt=\"\" width=\"1000\" height=\"709\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 602</strong></span></p>",
      "correct_choice_id": 19723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32322,
      "choices": [
        {
          "id": 129142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic acidosis</span></span></span></span></p>"
        },
        {
          "id": 129143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic alkalosis</span></span></span></span></p>"
        },
        {
          "id": 129144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory acidosis</span></span></span></span></p>"
        },
        {
          "id": 129145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory alkalosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the acid base disorder in a patient with the following values: pH- 7.2 and pCO<sub>2</sub> &ndash; 80 mm Hg?</span></span></span></span>&nbsp;(NEET PG 2022)</p>",
      "unique_key": "Q9138972",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136804,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Respiratory acidosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As pH = 7.2 of the patient&rsquo;s blood is lower than normal blood pH= 7.35-7.45, so, it&rsquo;s a case of acidosis. As the acidosis is due to pCO<sub>2</sub> = 80 mm of Hg that is higher than normal pCO<sub>2 </sub>= 35-45 mm of Hg, so, it&rsquo;s a case of respiratory acidosis rather than metabolic acidosis which occurs due to decreased HCO<sub>3</sub><sup>-</sup> ions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Metabolic acidosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is characterized by a decrease in blood pH due to a primary reduction in bicarbonate (HCO3-) levels. It is not associated with elevated pCO2 levels, which are seen in respiratory acidosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Metabolic alkalosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is characterized by an increase in blood pH due to a primary increase in bicarbonate (HCO3-) levels. It is not consistent with the low pH and high pCO2 levels seen in the patient.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Respiratory alkalosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is characterized by an increase in blood pH due to a primary decrease in pCO2 levels, often caused by hyperventilation. It is the opposite of the patient&#39;s condition, which shows low pH and high pCO2 levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory acidosis is indicated by a low blood pH and elevated pCO2 levels, suggesting impaired respiratory function and CO2 retention as the primary cause of the acidosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dinesh Puri 3<sup>rd</sup> ed/pg-15</span></span></strong></p>",
      "correct_choice_id": 129144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31800,
      "choices": [
        {
          "id": 127070,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Aspergillus niger: Voriconazole </span></span></span></p>"
        },
        {
          "id": 127071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Aspergillus fumigatus: Micafungin </span></span></span></p>"
        },
        {
          "id": 127072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Candida glabrata: Amphotericin B </span></span></span></p>"
        },
        {
          "id": 127073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Candida krusei: Fluconazole</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Which of the following organism is intrinsically resistant to the given drug? </span></span></span></p>",
      "unique_key": "Q1458230",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:#343541\"><strong>Ans. D)</strong>&nbsp;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:#343541\"><strong>Candida krusei: Fluconazole</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Candida krusei is known to have intrinsic resistance to fluconazole, which means that this organism generally does not respond to treatment with fluconazole. This is due to a combination of mechanisms including alterations in the target enzyme lanosterol 14-&alpha;-demethylase, efflux pump activity, and changes in membrane sterols. Therefore, for infections caused by Candida krusei, alternative antifungal agents such as amphotericin B, echinocandins, or voriconazole are typically considered.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">In the clinical setting, the intrinsic resistance of Candida krusei to fluconazole is significant, as fluconazole is often used as a first-line agent for the treatment of Candida infections. The presence of Candida krusei may therefore necessitate a shift in the standard therapeutic approach and prompt the use of different antifungal therapy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"color:#343541\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option </strong><span style=\"color:#343541\"><strong>A.</strong>&nbsp;</span><span style=\"color:#343541\"><strong>Aspergillus niger: Voriconazole</strong> Voriconazole is a broad-spectrum antifungal that is effective against most species of Aspergillus, including Aspergillus niger. It is often used as a first-line treatment for invasive aspergillosis. Therefore, Aspergillus niger is not intrinsically resistant to voriconazole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option <span style=\"color:#343541\">B. Aspergillus fumigatus: Micafungin</span></strong><span style=\"color:#343541\"> Aspergillus fumigatus is generally susceptible to micafungin. Micafungin belongs to the echinocandin class of antifungal drugs, which are effective against most Aspergillus species, but echinocandins are not the first choice for the treatment of aspergillosis. They are typically used as second-line agents or in combination therapy for Aspergillus infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option </strong><span style=\"color:#343541\"><strong>C.</strong>&nbsp;</span><span style=\"color:#343541\"><strong>Candida glabrata: Amphotericin B</strong> Candida glabrata can be susceptible to amphotericin B, but it is known for having a dose-dependent sensitivity or a reduced susceptibility. Some strains may show resistance, but this is not considered intrinsic resistance. Instead, amphotericin B resistance in C. glabrata can be due to acquired mechanisms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-111101.jpg\" style=\"height:391px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"color:#343541\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Candida krusei is intrinsically resistant to fluconazole, necessitating the use of alternative antifungal agents for treatment.</span></span></p>",
      "correct_choice_id": 127073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4943,
      "choices": [
        {
          "id": 19746,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiamine</span></p>"
        },
        {
          "id": 19747,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 19748,
          "text": "<p><span style=\"font-size:12.0pt;\">Zinc</span></p>"
        },
        {
          "id": 19749,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vitamin deficiency causes this?(NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture6.jpg\" alt=\"\" width=\"300\" height=\"272\"></span></p>",
      "unique_key": "Q5986572",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136814,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Niacin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is&nbsp;Casal’s necklace&nbsp;shown in picture, which occurs in&nbsp;Vitamin B<sub>3</sub>/ Niacin deficiency. Niacin can be formed in the body from amino acid tryptophan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Thiamine (Vitamin B1)</strong>: Thiamine is an essential B-vitamin that plays a crucial role in energy metabolism. It helps the body convert food (carbohydrates) into energy (ATP). Thiamine is important for the proper functioning of nerves and muscles. Deficiency can lead to conditions like beriberi and Wernicke-Korsakoff syndrome, which affect the nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Zinc</strong>: Zinc is a trace mineral that is crucial for the immune system, wound healing, and DNA synthesis. It also plays a role in maintaining a sense of taste and smell. Zinc deficiency can lead to impaired immune function, delayed wound healing, and other health issues. It is an essential nutrient for overall health.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pyridoxine (Vitamin B6)</strong>: Pyridoxine is another B-vitamin that is involved in various metabolic processes, including amino acid metabolism and neurotransmitter synthesis. It plays a role in maintaining brain health and proper nerve function. Pyridoxine deficiency can lead to symptoms like anemia, nerve damage, and skin issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Niacin is another B-vitamin that is essential for various bodily functions. It plays a role in converting nutrients into energy, creating cholesterol and fats, repairing DNA, and acting as an antioxidant. Niacin is important for overall metabolic health. Severe niacin deficiency can lead to a condition called pellagra, which can have serious effects on the skin, digestive system, and nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Niacin deficiency can be caused by:</span></p><ul><li><span style=\"font-size:12.0pt;\">Dietary deficiency of tryptophan</span></li><li><span style=\"font-size:12.0pt;\">Dietary deficiency Vitamin B2 and B6 deficiency</span></li><li><span style=\"font-size:12.0pt;\">Carcinoid syndrome</span></li><li><span style=\"font-size:12.0pt;\">Hartnup’s disease</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 534-535</strong></span></p>",
      "correct_choice_id": 19747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54302,
      "choices": [
        {
          "id": 216677,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
        },
        {
          "id": 216678,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 216679,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
        },
        {
          "id": 216680,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following clinical features can be encountered in Korsakoff psychosis?</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amnesia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Confabulation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ophthalmoplegia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral neuropathy</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2519285",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137462,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) 1, 2, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Korsakoff psychosis, or Korsakoff syndrome, is a chronic neuropsychiatric syndrome resulting from </span><span style=\"font-size:12.0pt\">chronic </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">deficiency </span><span style=\"font-size:12.0pt\">of</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> thiamine (vitamin B1), commonly associated with chronic alcoholism. It is often considered an irreversible condition, unlike its acute counterpart, Wernicke&#39;s encephalopathy, which can be treated with thiamine supplementation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features of Korsakoff Psychosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amnesia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Korsakoff syndrome is characterized by severe memory impairment, both anterograde (inability to form new memories) and retrograde (loss of previously formed memories) amnesia. Long-term memory, however, tends to remain relatively intact.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Confabulation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Patients often exhibit confabulation, where they fabricate stories to fill gaps in their memory. This is not intentional lying but a way to compensate for memory loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral Neuropathy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Chronic alcoholics often suffer from peripheral neuropathy due to thiamine deficiency and direct neurotoxic effects of alcohol. This neuropathy involves the axons of peripheral nerves and manifests as numbness, tingling, and pain in the extremities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Not a Feature of Korsakoff Psychosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ophthalmoplegia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a feature of Wernicke&#39;s encephalopathy, which presents acutely with a triad of ophthalmoplegia, ataxia, and confusion. Ophthalmoplegia refers to paralysis or weakness of the eye muscles. It is reversible with thiamine treatment and is not typically seen in the chronic phase of Korsakoff syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Korsakoff psychosis is characterized by severe memory impairment (amnesia), confabulation, and peripheral neuropathy. It does not include ophthalmoplegia, which is a feature of the acute Wernicke&#39;s encephalopathy.</span></span></p>",
      "correct_choice_id": 216677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3460,
      "choices": [
        {
          "id": 13819,
          "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus granulosus</span></p>"
        },
        {
          "id": 13820,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma japonicum</span></p>"
        },
        {
          "id": 13821,
          "text": "<p><span style=\"font-size:12.0pt;\">Trypanosoma cruzi</span></p>"
        },
        {
          "id": 13822,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosoma mansoni</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the causative organism for the condition shown in the image below?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-256.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
      "unique_key": "Q4996812",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137441,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Echinococcus granulosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows a hydatid cyst in the liver. Large, unilocular/multilocular, well-defined, hypodense cysts. Contains multiple internal “daughter” cysts of lower density than “mother” cyst (exocyst). Curvilinear ring-like calcification of pericyst (wall).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Causative organism – Echinococcus granulosus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Definitive hosts – Dogs, Intermediate host – Sheep, Accidental intermediate host – Human</strong> (end stage host)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the liver, the pressure effect of the cyst can produce symptoms of <u>obstructive jaundice</u> and abdominal pain. <u>With biliary rupture, the classic triad of biliary colic, jaundice, and urticaria</u> is observed. Passage of hydatid membranes in the emesis (hydatid emesia) and passage of membranes in the stools (hydatid enterica) may occur rarely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-26.jpg\" alt=\"\" width=\"700\" height=\"514\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Schistosoma japonicum</strong>: This parasitic worm causes schistosomiasis, primarily affecting the intestines and liver, but it does not form hydatid cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Trypanosoma cruzi</strong>: This protozoan parasite causes Chagas disease, which primarily affects the heart and digestive system, not forming cysts in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Schistosoma mansoni</strong>: This parasitic worm also causes schistosomiasis, affecting the intestines and liver, but it does not form hydatid cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The condition shown in the image, characterized by a hydatid cyst in the liver, is caused by Echinococcus granulosus. The cysts contain internal daughter cysts and can lead to symptoms related to the pressure effect on the liver and biliary system.</span></p>",
      "correct_choice_id": 13819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10230,
      "choices": [
        {
          "id": 40886,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 12 months</span></p>"
        },
        {
          "id": 40887,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 12 months</span></p>"
        },
        {
          "id": 40888,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 6 months</span></p>"
        },
        {
          "id": 40889,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 35-year-old patient presents to the outpatient department with a satellite skin lesion. On examination, the patient has one hypopigmented lesion and one thickened nerve. The images of two blister packs are provided. Based on the WHO / NLEP Guidelines, which treatment is most appropriate for this patient?</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture2_e7rPz6c.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q8554025",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137460,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<h3><span style=\"color:#1F3763;font-size:10.5pt;\">Answer:</span></h3><p><span style=\"font-size:10.5pt;\">The correct answer is <strong>B. Packet 2 for 12 months</strong>.</span></p><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p>&nbsp;</p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:494.25pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>World health organization (WHO)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\">No&nbsp;</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\">≥1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><span style=\"font-size:10.5pt;\"><i>*If a case has any one of the three features suggestive of MB, he/she is classified as MB.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:13.5pt;\"><strong>Treatment Regimen: WHO &amp; NLEP (Post April 1st 2025)</strong></span></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TAhJtvE.png\" alt=\"A chart of medication\r\n\r\n\r\n\r\n\r\n\r\nDescription automatically generated with medium confidence\" width=\"337\" height=\"172\"></span></p><figure class=\"image\"><img style=\"aspect-ratio:184/239;\" src=\"https://tnhealth.tn.gov.in/tngovin/dph/images/mbadultdose.png\" alt=\"Health &amp; Family Welfare Department, Government of Tamil Nadu\" width=\"184\" height=\"239\"></figure><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QuOAkXI.png\" width=\"463\" height=\"250\"></span></p><p>&nbsp;</p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Other Options:</span></h3><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option A: Packet 1 for 12 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option C: Packet 1 for 6 months:&nbsp;</strong></span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option D Packet 2 for 6 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">Although Packet 2 contains the correct medications, the treatment duration of 6 months is insufficient for multibacillary leprosy according to WHO guidelines, which recommends 12 months.</span></p><p>&nbsp;</p><p><strong>OLD NLEP GUIDELINES to diagnose Leprosy&nbsp;</strong></p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:469.5pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>National Leprosy Eradication Programme (NLEP)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\">No or 1 nerve</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\">&gt;1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><strong>OLD NLEP GUIDELINES to treat Leprosy&nbsp;</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cv8eRBC.png\" alt=\"A chart of drugs and drugs\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"243\"></p><p><strong>OLD PB MDT with 2 drugs followed by NLEP:</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F3OLXAd.png\" alt=\"A green label with black circles and white text\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"257\"></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><i><strong>Educational objective:</strong></i></span></p><ul><li>As of <strong>April 1, 2025</strong>, <strong>NLEP follows WHO guidelines</strong> for both <strong>diagnosis and treatment</strong>.</li><li>Classification is based on <strong>skin lesions</strong>, <strong>nerve involvement</strong>, and <strong>skin smear</strong>.</li><li><span style=\"font-size:10.5pt;\">For a patient with <i><strong>multibacillary leprosy</strong></i>, characterized by <i><strong>one or more thickened nerves</strong></i> and <i><strong>multiple skin lesions</strong></i>, the appropriate treatment is with a regimen containing <i><strong>rifampicin, clofazimine, and dapsone (Packet 2)</strong></i> for a duration of <i><strong>12 months.</strong></i></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Jopling’s handbook of leprosy, 6<sup>th</sup> edition, page no 10</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Andrew’s diseases of the skin: clinical dermatology 13<sup>th</sup> edition page no 338, 339, 345</strong></span></p>",
      "correct_choice_id": 40887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32292,
      "choices": [
        {
          "id": 129026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1</span></span></span></span></p>"
        },
        {
          "id": 129027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-2</span></span></span></span></p>"
        },
        {
          "id": 129028,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-4</span></span></span></span></p>"
        },
        {
          "id": 129029,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-2</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child is presented with multiple times loose stools. He is managed with ORS. Glucose in ORS is absorbed via which transporter in GIT?(NEET PG 2021)</span></span></span></span></p>",
      "unique_key": "Q8139329",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136819,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) SGLT-1</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium-Glucose Transporter 1</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1 is a transporter protein located in the small intestine. It plays a crucial role in the absorption of glucose and sodium from the gut lumen into the enterocytes (intestinal cells). In the context of ORS, SGLT-1 facilitates the absorption of glucose, which helps in the rehydration process by increasing fluid absorption.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose and galactose are absorbed from intestinal lumen into intestinal cell via secondary active transport using sodium dependent glucose transporter (SGLT-1). On the other hand, the glucose from the intestine cell in to blood at basolateral membrane is transported via passive transporter GLUT-2 (see fig)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture9.jpg\" style=\"height:341px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. SGLT-2 (Sodium-Glucose Transporter 2)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-2 is primarily found in the proximal renal tubules of the kidney and is responsible for the reabsorption of glucose from the urine. It is not involved in the absorption of glucose from the gastrointestinal tract.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. GLUT-4 (Glucose Transporter 4)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-4 is a glucose transporter primarily found in muscle and adipose tissue. It is responsible for insulin-mediated glucose uptake into these tissues and is not related to glucose absorption in the gut.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GLUT-2 (Glucose Transporter 2)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-2 is a glucose transporter found in the liver, pancreatic beta cells, and the basolateral membrane of enterocytes. It is involved in glucose uptake by the liver and pancreas and is not the primary transporter for glucose absorption in the gut.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1 is the key transporter responsible for the absorption of glucose in the gastrointestinal tract. This mechanism is crucial in the management of conditions like diarrhea, where ORS containing glucose can help rehydrate the body by enhancing fluid absorption.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">-Harper 31<sup>st</sup> e/pg. 538</span></span></strong></span></span></p>",
      "correct_choice_id": 129026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43950,
      "choices": [
        {
          "id": 175463,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand disease</span></p>"
        },
        {
          "id": 175464,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemophilia A</span></p>"
        },
        {
          "id": 175465,
          "text": "<p><span style=\"font-size:12.0pt;\">Christmas disease</span></p>"
        },
        {
          "id": 175466,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor 12 Deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old female with bleeding disorder, gives family history of her father and sister suffering from the&nbsp;same bleeding disorders. Which is the most likely disorder? (</span><span style=\"font-size:11.0pt;\">INICET NOV 2023)</span></p>",
      "unique_key": "Q3357726",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137456,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Von Willebrand disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Von Willebrand disease is a common inherited bleeding disorder that affects both males and females, and it is typically inherited in an autosomal dominant pattern. This means that males and females have an equal chance of inheriting the disorder from a parent, which is consistent with the family history provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemophilia A:&nbsp;</strong>This is a X-linked recessive disorder primarily affecting males; females are typically carriers unless under rare circumstances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Christmas Disease (Hemophilia B):&nbsp;</strong>Similar to Hemophilia A, this condition is also X-linked recessive, predominantly affecting males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Factor 12 Deficiency</strong>: This is a much rarer condition and usually does not lead to significant bleeding issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Von Willebrand disease is characterized by its autosomal dominant inheritance pattern and affects both genders, making it the most likely diagnosis for a female patient with a family history of bleeding disorders involving both male and female family members.</span></p>",
      "correct_choice_id": 175463,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13855,
      "choices": [
        {
          "id": 55381,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Oculomotor nerve</span></p>"
        },
        {
          "id": 55382,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Olfactory nerve</span></p>"
        },
        {
          "id": 55383,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Optic nerve</span></p>"
        },
        {
          "id": 55384,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Facial nerve</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the cranial nerve that passes through the marked foramen marked 2 in the image below: (AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-54.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
      "unique_key": "Q9008805",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137446,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Oculomotor nerve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The marked structure is the superior orbital fissure and the oculomotor nerve passes through this fissure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Superior orbital fissure is divided into three compartments by the common tendinous ring. The oculomotor nerve passes through its intermediate compartment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-55.jpg\" alt=\"\" width=\"500\" height=\"325\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The oculomotor nerve primarily controls the movements of several eye muscles, including the levator palpebrae superioris (lifts the upper eyelid), and the superior, inferior, and medial rectus muscles, which control eye movements. It also controls the constriction of the pupil (miosis) and accommodation of the lens for near vision.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Olfactory Nerve (CN I):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The olfactory nerve originates from the <strong>olfactory bulbs</strong>, which are extensions of the brain, located on the <strong>cribriform plate</strong> of the <strong>ethmoid bone</strong> within the anterior cranial fossa.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The olfactory nerve is responsible for the sense of smell. It carries sensory information related to odors from the nasal cavity to the olfactory bulbs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Optic Nerve (CN II):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The optic nerve emerges from the <strong>optic canal</strong>, which is located in the <strong>lesser wing of the sphenoid bone</strong> within the middle cranial fossa.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The optic nerve is crucial for vision. It transmits visual information from the retina to the brain, allowing us to perceive and interpret visual stimuli.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Facial Nerve (CN VII):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The facial nerve emerge from a stylomastoid foramen from the base of the skull.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It controls the muscles of facial expression, taste sensation from the anterior two-thirds of the tongue, and the production of saliva and tears. It also carries sensory information related to taste.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-56.jpg\" alt=\"\" width=\"500\" height=\"556\"></span></p>",
      "correct_choice_id": 55381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5056,
      "choices": [
        {
          "id": 20198,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher’s disease</span></p>"
        },
        {
          "id": 20199,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay Sach’s disease</span></p>"
        },
        {
          "id": 20200,
          "text": "<p><span style=\"font-size:12.0pt;\">Hunter syndrome</span></p>"
        },
        {
          "id": 20201,
          "text": "<p><span style=\"font-size:12.0pt;\">Krabbe’ disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cherry red spots on retina and mental retardation is seen in: (NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture13.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
      "unique_key": "Q5347755",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136793,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tay Sach’s disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct answer. Tay-Sachs disease is characterized by cherry red spots on the retina, which are a distinctive sign of the condition. It is also associated with mental retardation and neurological symptoms. Tay-Sachs is a rare genetic disorder that affects the central nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Gaucher's Disease:&nbsp;</strong>Cherry red spots on the retina are not a typical feature of Gaucher's disease. Gaucher's disease primarily affects the spleen, liver, and bone marrow, leading to symptoms such as anemia, enlarged liver and spleen, and bone pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Hunter Syndrome:&nbsp;</strong>Cherry red spots on the retina are not a common feature of Hunter syndrome. Hunter syndrome primarily affects connective tissues and leads to symptoms such as joint stiffness and organ enlargement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Krabbe’s Disease:&nbsp;</strong>Cherry red spots on the retina are not typically seen in Krabbe disease. Krabbe disease is a rare genetic disorder that affects the nervous system and leads to symptoms like muscle weakness and developmental delay.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hallmark feature of Tay-Sachs disease is the presence of \"cherry red spots\" on the retina of the eye. These spots are a distinctive sign observed during eye examinations. Additionally, individuals with Tay-Sachs disease often experience progressive neurological deterioration, including muscle weakness, loss of motor skills, and seizures. There is also a characteristic decline in cognitive function, leading to intellectual and developmental disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 235</strong></span></p>",
      "correct_choice_id": 20199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60457,
      "choices": [
        {
          "id": 241121,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Repeat surgery</span></span></p>"
        },
        {
          "id": 241122,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Macrolides for 4 months</span></span></p>"
        },
        {
          "id": 241123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Steroid irrigation and antihistamines</span></span></p>"
        },
        {
          "id": 241124,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Biological therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female patient presents with complaints of nasal obstruction and post-nasal drip. There is a past history of FESS for failed conservative management 5 years ago. Uncinectomy and maxillary ostium dilation were done during the previous FESS. A DNE done now shows patent ostia and mucosal edema of the maxillary sinus lining. What is the next best step in management?</span><span style=\"background-color:lime\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>",
      "unique_key": "Q5705187",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137436,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Steroid irrigation and antihistamines</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The history of <strong>nasal obstruction</strong> and <strong>post-nasal drip</strong> with endoscopy findings of <strong>mucosal edema</strong> suggests the presence of <strong>acute rhinosinusitis</strong>. The next best management involves <strong>nasal steroid irrigation</strong> along with <strong>antihistamines</strong> to reduce the mucosal inflammation, congestion, and edema. Even though the patient underwent FESS (Functional Endoscopic Sinus Surgery) 5 years ago, the patent ostia indicate that the surgery was successful in creating drainage pathways, but inflammation persists.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acute viral rhinosinusitis often leads to <strong>mucosal edema</strong>, which can obstruct the sinus ostia and impair mucociliary clearance, causing symptoms like headache, facial pain, and nasal congestion. <strong>Steroid irrigation</strong> and <strong>antihistamines</strong> are used to reduce this inflammation and promote drainage.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Repeat surgery:</strong> Repeat surgery is not indicated because the DNE (Diagnostic Nasal Endoscopy) findings show <strong>patent ostia</strong>, indicating no structural blockage requiring surgical correction. Surgery is reserved for patients with failed medical management or irreversible anatomical issues.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Macrolides for 4 months:</strong> Macrolides (such as azithromycin) are not routinely used for long-term management of rhinosinusitis unless there is chronic bacterial infection or the patient shows signs of immune deficiency. In this case, no bacterial infection is present, and there are no signs of infection requiring antibiotics.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Biological therapy:</strong> Biological therapies (e.g., monoclonal antibodies) are considered in refractory chronic sinusitis with polyps, especially when associated with conditions like asthma. However, they are not standard treatments for uncomplicated rhinosinusitis with mucosal edema.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Nasal steroid irrigation</strong> and <strong>antihistamines</strong> are the next best step in the management of acute rhinosinusitis with mucosal edema and patent sinus ostia, especially in patients with previous sinus surgery. This approach reduces inflammation and edema to restore normal sinus drainage.</span></span></p>",
      "correct_choice_id": 241123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10098,
      "choices": [
        {
          "id": 40358,
          "text": "<p><span style=\"font-size:12.0pt;\">Surfactant</span></p>"
        },
        {
          "id": 40359,
          "text": "<p><span style=\"font-size:12.0pt;\">Humectant</span></p>"
        },
        {
          "id": 40360,
          "text": "<p><span style=\"font-size:12.0pt;\">Emulsifier</span></p>"
        },
        {
          "id": 40361,
          "text": "<p><span style=\"font-size:12.0pt;\">Preservative</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Methylisothiazolinone (MI) in cosmetics is used as? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q7135313",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Preservative</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Methylisothiazolinone (MIT)&nbsp;</strong>is a <strong>preservative present</strong> in various <strong>facial cosmetics, deodorants, sunscreens, and industrial products</strong>. The frequency of contact dermatitis resulting from either <strong>Methyl-chloro-isothiazolinone/methylisothiazolinone (MCI/MIT or Kathon CG) or MIT</strong> has been on the rise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13549.jpg\" alt=\"\" width=\"400\" height=\"318\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Moreover, there have been reported cases of severe <strong>airborne</strong> and <strong>generalized dermatitis</strong> caused by exposure to <strong>MIT</strong> through recently <strong>painted walls</strong> and even from <strong>toilet cleaners.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-101311.jpg\" alt=\"\" width=\"1000\" height=\"548\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's important to understand that <strong>Methylisothiazolinone (MI)</strong> is used as a <strong>preservative</strong> in <strong>cosmetics</strong> to prevent <strong>microbial growth</strong>, distinguishing it from surfactants, humectants, and emulsifiers, which have different functional roles in product formulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref:</strong></span></p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Rook's Textbook of Dermatology - 9th Edition - Volume I, Chapter 128, Page no 128.36</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Online resources: </strong></span><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689087/\"><span style=\"font-size:12.0pt;\"><strong>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689087/</strong></span></a><span style=\"font-size:11pt;\"><strong> &nbsp;</strong></span></p>",
      "correct_choice_id": 40361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32673,
      "choices": [
        {
          "id": 130542,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B9</span></p>"
        },
        {
          "id": 130543,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 130544,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        },
        {
          "id": 130545,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person presented with neurological manifestations mimicking UMN (Upper Motor Neuron) palsy and sensory neuropathy. The patient was pale and investigations revealed anemia. The probable micronutrient deficiency is?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q9913393",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136784,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin B12</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The neurological manifestations mimicking Upper Motor Neuron (UMN) palsy and sensory neuropathy, along with the presence of anemia, suggest a possible vitamin B12 deficiency. It can cause a type of anemia known as megaloblastic anemia, which can present with pale skin. Moreover, B12 deficiency can also lead to neurological symptoms such as UMN palsy and sensory neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Vitamin B9 (Folate):</strong> Folate deficiency can lead to anemia, but it is not typically associated with neurological manifestations resembling UMN palsy and sensory neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Vitamin B3 (Niacin):</strong> Niacin deficiency can cause pellagra, which is characterized by dermatitis, diarrhea, and dementia. While it involves neurological symptoms, it doesn't typically mimic UMN palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Vitamin B1 (Thiamine):</strong> Thiamine deficiency can cause beriberi, a condition that primarily affects the cardiovascular and nervous systems. However, it is not typically associated with symptoms mimicking UMN palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency can lead to a variety of neurological symptoms, including UMN-like signs and sensory neuropathy, due to its essential role in nerve function. This deficiency can result from dietary inadequacy or malabsorption, leading to anemia and neurological complications. It's crucial to recognize the clinical presentation of vitamin B12 deficiency to provide appropriate treatment and prevent long-term neurological damage.</span></p>",
      "correct_choice_id": 130543,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5046,
      "choices": [
        {
          "id": 20158,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyanide</span></p>"
        },
        {
          "id": 20159,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbon Dioxide</span></p>"
        },
        {
          "id": 20160,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligomycin</span></p>"
        },
        {
          "id": 20161,
          "text": "<p><span style=\"font-size:12.0pt;\">Antimycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Complex 4 inhibitor is? (</span>NEET PG 2022)</p>",
      "unique_key": "Q6476986",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136790,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cyanide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Cyanide is a potent inhibitor of Complex IV (cytochrome c oxidase) in the electron transport chain (ETC). Complex IV is crucial for the final step of the electron transport chain, where it facilitates the transfer of electrons to oxygen, the final electron acceptor, to form water. By inhibiting Complex IV, cyanide prevents the reduction of oxygen, halting ATP production and leading to cellular hypoxia and energy failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Carbon Dioxide:&nbsp;</strong>Carbon dioxide is not an inhibitor of any of the electron transport chain complexes. It is a byproduct of cellular respiration and does not interfere with the function of the ETC complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Oligomycin:&nbsp;</strong>Oligomycin is an inhibitor of ATP synthase (Complex V) in the electron transport chain. It binds to the F0 subunit of ATP synthase, blocking the proton channel and preventing proton translocation across the inner mitochondrial membrane. This inhibition halts ATP synthesis from ADP and inorganic phosphate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Antimycin:&nbsp;</strong>Antimycin is an inhibitor of Complex III (cytochrome bc1 complex) in the electron transport chain. It binds to the Qi site of cytochrome c reductase, blocking the transfer of electrons from ubiquinol to cytochrome c, disrupting the proton gradient and halting ATP synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inhibitor of ETC complexes</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-163056.jpg\" alt=\"\" width=\"1000\" height=\"543\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 123</strong></span></p>",
      "correct_choice_id": 20158,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5062,
      "choices": [
        {
          "id": 20222,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiamine</span></p>"
        },
        {
          "id": 20223,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutathione reductase</span></p>"
        },
        {
          "id": 20224,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexokinase</span></p>"
        },
        {
          "id": 93759,
          "text": "<p><span style=\"font-size:12.0pt;\">Transketolase</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">FAD status in body is determined by?(NEET PG 2022)</span></p>",
      "unique_key": "Q9144735",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136794,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glutathione reductase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct answer. Glutathione reductase is an enzyme that contains FAD as a prosthetic group and plays a significant role in the reduction of glutathione disulfide (GSSG) to glutathione (GSH). The activity of glutathione reductase, which depends on the availability of FAD, can be used to assess tissue riboflavin (FAD precursor) status. Therefore, measuring the activity of glutathione reductase with and without FAD is a method for assessing FAD status in the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Thiamine:&nbsp;</strong>Thiamine, also known as Vitamin B1, is not directly involved in determining FAD status. Thiamine plays a crucial role in carbohydrate metabolism but doesn't directly influence the levels of FAD in the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Hexokinase:&nbsp;</strong>Hexokinase is an enzyme involved in the first step of glucose metabolism, but it is not responsible for determining FAD status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Transketolase:&nbsp;</strong>Transketolase is marker enzyme for B1 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FAD is the active form of Vitamin B<sub>2</sub> and marker for the B<sub>2</sub> deficiency is RBC glutathione reductase activity as this enzyme require B<sub>2 </sub>as coenzyme. So, in case of FAD deficiency, glutathione reductase activity will be lowered without affecting the quantity of enzyme.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 534</strong></span></p>",
      "correct_choice_id": 20223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4955,
      "choices": [
        {
          "id": 19794,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligomycin</span></p>"
        },
        {
          "id": 19795,
          "text": "<p><span style=\"font-size:12.0pt;\">2,4 dinitrophenol</span></p>"
        },
        {
          "id": 19796,
          "text": "<p><span style=\"font-size:12.0pt;\">Antimycin</span></p>"
        },
        {
          "id": 19797,
          "text": "<p><span style=\"font-size:12.0pt;\">Rotenone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In an isolated mitochondria, in a medium containing Succinate, Fumarate, ADP and Pi, ATPs were produced. Later a compound was added, and oxidative phosphorylation was decreased. What’s that compound?&nbsp;(NEET PG 2021)</span></p>",
      "unique_key": "Q4156392",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136816,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Oligomycin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Oligomycin is an antibiotic that inhibits ATP synthase, a key enzyme complex in oxidative phosphorylation. It blocks the flow of protons (H+) through ATP synthase, preventing ATP synthesis. As a result, adding oligomycin would indeed decrease oxidative phosphorylation, leading to a reduction in ATP production.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 2,4-dinitrophenol (DNP)</strong>: 2,4-dinitrophenol is a chemical uncoupler of oxidative phosphorylation. It disrupts the proton gradient across the inner mitochondrial membrane, making it leaky to protons. This uncoupling reduces the efficiency of ATP production but doesn't directly inhibit oxidative phosphorylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Antimycin</strong>: Antimycin is an inhibitor of complex III (cytochrome bc1 complex) in the electron transport chain. It blocks the transfer of electrons from ubiquinone to cytochrome c, disrupting the electron flow in the chain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rotenone</strong>: Rotenone is an inhibitor of complex I in the electron transport chain. It prevents the transfer of electrons from NADH to ubiquinone, disrupting electron flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Oligomycin specifically targets ATP synthase and inhibits ATP synthesis in oxidative phosphorylation. Therefore, the compound that was added to the isolated mitochondria, leading to a decrease in oxidative phosphorylation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 123</strong></span></p>",
      "correct_choice_id": 19794,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34052,
      "choices": [
        {
          "id": 136043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 4 </span></span></span></p>"
        },
        {
          "id": 136044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1,2,3</span></span></span></p>"
        },
        {
          "id": 136045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1,3,4</span></span></span></p>"
        },
        {
          "id": 136046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2,3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">First part of PCT has which of the following transport proteins? (</span></span></span>INICET Nov 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium potassium pump</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na- glucose co-transporter</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium hydrogen antiport</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na<sup>+</sup> Bicarbonate cotransporter </span></span></span></li>\r\n</ol>",
      "unique_key": "Q5092745",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 1,2,3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Sodium-potassium pump:</span></strong><span style=\"font-size:12.0pt\"> This transporter is found on the basolateral side of the proximal convoluted tubule (PCT) cells and is critical for maintaining the sodium gradient that drives other transport processes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Na-glucose co-transporter:</span></strong><span style=\"font-size:12.0pt\"> This is located on the apical membrane of PCT cells and uses the sodium gradient to co-transport glucose from the tubular lumen into the cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Sodium-hydrogen antiport:</span></strong><span style=\"font-size:12.0pt\"> Also on the apical membrane, this antiporter exchanges sodium from the tubular lumen with hydrogen ions from the cell, playing a key role in sodium reabsorption and pH balance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Option</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Na+ Bicarbonate cotransporter:</span></strong><span style=\"font-size:12.0pt\"> It is present in the distal or late part of PCT (Not in the early PCT)- contributes to bicarbonate reabsorption.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct combination based on the provided answer is b) 1,2,3, which includes the sodium-potassium pump, the Na-glucose co-transporter, and the sodium-hydrogen antiport, all of which are essential for the function of the PCT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proximal convoluted tubule &ndash; transport processes &ndash; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/14.jpg\" style=\"height:291px; width:1000px\" /></p>",
      "correct_choice_id": 136044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14014,
      "choices": [
        {
          "id": 56017,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide bore needle insertion in the 5th intercostal space (ICS)</span></p>"
        },
        {
          "id": 56018,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide bore needle insertion in the 5th ICS followed by an intercostal drain in the 5th ICS</span></p>"
        },
        {
          "id": 56019,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspiration of the pleural fluid</span></p>"
        },
        {
          "id": 56020,
          "text": "<p><span style=\"font-size:12.0pt;\">No intervention needed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female patient was brought to the ER after RTA, her RR is 22/min, BP is 90/60mmHg. On examination, hyper-resonance is heard over the right side of the chest. The chest X-ray performed is given below. What would be the appropriate management in this case? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-95_9PDkssD.jpg\" alt=\"\" width=\"208\" height=\"239\"></span></p>",
      "unique_key": "Q6977703",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137445,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Wide bore needle insertion in the 5th ICS followed by an intercostal drain in the 5th ICS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given scenario of tachypnea, hypotension, hyper-resonance and x ray showing absent right broncho-vascular markings is suggestive of tension pneumothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This option correctly addresses the likely diagnosis of a pneumothorax. The initial needle insertion can decompress the tension pneumothorax, and subsequent placement of an intercostal drain allows for continuous drainage of pleural air or fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. Wide bore needle insertion in the 5th ICS</strong>: This option suggests inserting a needle into the 5th ICS to relieve tension pneumothorax, which can occur due to trauma. While this can be a life-saving procedure, the presence of hyper-resonance on examination suggests a pneumothorax, but it does not address the drainage of pleural fluid, which is the primary concern in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspiration of the pleural fluid</strong>: Aspiration of pleural fluid may be indicated in cases of pleural effusion, but it does not address the likely pneumothorax seen in this patient's presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>No intervention needed</strong>: With the patient's clinical presentation, including respiratory distress, low blood pressure, and hyper-resonance, intervention is indeed needed. Failure to intervene could lead to worsening respiratory compromise and potentially life-threatening consequences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tension pneumothorax usually occurs due to trauma, such as a rib fracture, a puncture wound, or chest surgery, but it can also develop spontaneously in patients with underlying lung diseases, such as emphysema or cystic fibrosis.</span></li><li><span style=\"font-size:12.0pt;\">Immediate treatment of tension pneumothorax is essential to prevent respiratory and cardiac arrest. The first step is to perform needle decompression, which involves inserting a large-bore needle into the affected side of the chest to release the trapped air in the triangle of safety. After that, a chest tube is inserted to further drain the air and prevent the reoccurrence of a pneumothorax.</span></li></ul>",
      "correct_choice_id": 56018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44031,
      "choices": [
        {
          "id": 175783,
          "text": "<p><span style=\"font-size:12pt;\">Integrin</span></p>"
        },
        {
          "id": 175784,
          "text": "<p><span style=\"font-size:12pt;\">Cadherin</span></p>"
        },
        {
          "id": 175785,
          "text": "<p><span style=\"font-size:12pt;\">Occludens</span></p>"
        },
        {
          "id": 175786,
          "text": "<p><span style=\"font-size:12pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which extracellular cell adhesion is disrupted by Vibrio cholerae? (INICET NOV 2023)</span></p>",
      "unique_key": "Q6616611",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137448,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Occludens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vibrio cholerae disrupts occludens, specifically targeting tight junctions between intestinal epithelial cells, which impairs their barrier function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Integrin</strong>: Primarily involved in cell-extracellular matrix adhesion, not typically disrupted by Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cadherin</strong>: Important for cell-cell adhesion in adherens junctions, not the main target of Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. None of the above</strong>: Incorrect, as occludens are indeed affected by Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vibrio cholerae specifically targets occludens, which are crucial components of tight junctions, thereby compromising intestinal epithelial barrier functions.</span></p>",
      "correct_choice_id": 175785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20937,
      "choices": [
        {
          "id": 83712,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase A</span></p>"
        },
        {
          "id": 83713,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase</span></p>"
        },
        {
          "id": 83714,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelinase</span></p>"
        },
        {
          "id": 83715,
          "text": "<p><span style=\"font-size:12.0pt;\">α-1,4-Glucosidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with bone pain and hepatosplenomegaly. A trephine biopsy and aspirate show the following finding. Which of the following is the most likely enzyme deficient in this condition?(NEET &nbsp;PG 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/picture22.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
      "unique_key": "Q6581930",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136781,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glucocerebrosidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical vignette of a child with bone pain, hepatosplenomegaly, and trephine biopsy showing a cell with a characteristic crumpled tissue paper appearance points to diagnosis of Gaucher's disease, in which enzyme deficient is glucocerebrosidase (also known as beta-glucosidase).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-29%20134931.jpg\" width=\"1068\" height=\"764\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gaucher’s Disease</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-29%20135020.jpg\" width=\"866\" height=\"560\"></p>",
      "correct_choice_id": 83713,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32321,
      "choices": [
        {
          "id": 129138,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin A</span></span></span></span></p>"
        },
        {
          "id": 129139,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D</span></span></span></span></p>"
        },
        {
          "id": 129140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin E</span></span></span></span></p>"
        },
        {
          "id": 129141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin K</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman on anti-depressants presents with bleeding. She gives a history of bulky stools which sticks to the pan. Which of the following vitamin deficiency can cause bleeding in this condition?&nbsp;</span></span>&nbsp;(NEET PG 2022)</p>",
      "unique_key": "Q3492847",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136803,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Vitamin K</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Vitamin K:</strong> Vitamin K is essential for blood clotting, and its deficiency can lead to a bleeding tendency. Bulky stools that stick to the pan can be indicative of malabsorption issues, which could result in inadequate absorption of fat-soluble vitamins, including Vitamin K. This deficiency can lead to bleeding problems.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Vitamin A:&nbsp;</strong>Vitamin A deficiency is not typically associated with bleeding disorders but can lead to other health issues, including vision problems.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Vitamin D:&nbsp;</strong>Vitamin D deficiency can result in various symptoms, but it is not known to directly cause bleeding disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Vitamin E:&nbsp;</strong>Vitamin E deficiency may lead to neurological and muscle problems but is not a common cause of bleeding disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bulky, greasy stools that stick to the pan (often described as &quot;steatorrhea&quot;) can be indicative of malabsorption, a condition where the absorption of nutrients, including fat-soluble vitamins, is impaired. Vitamin K is a fat-soluble vitamin crucial for the synthesis of blood clotting factors in the liver. Deficiency of vitamin K can lead to impaired blood clotting and a tendency to bleed<strong>.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin K is a fat-soluble vitamin crucial for the synthesis of blood clotting factors in the liver. Deficiency of vitamin K can lead to impaired blood clotting and a tendency to bleed.Top of Form</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper&rsquo;s 31<sup>st</sup> ed/pg- 532</span></span></strong></p>",
      "correct_choice_id": 129141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5027,
      "choices": [
        {
          "id": 20082,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-Glucocerebroside</span></p>"
        },
        {
          "id": 20083,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelinase</span></p>"
        },
        {
          "id": 20084,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase</span></p>"
        },
        {
          "id": 20085,
          "text": "<p><span style=\"font-size:12.0pt;\">G-6-phosphatase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following histological image is seen in the patient who is complaining of growth failure and abdominal distension.&nbsp; Signs found were anemia, thrombocytopenia and bony pain. Which enzyme is deficient in this patient? (NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture10.jpg\" alt=\"\" width=\"300\" height=\"226\"></span></p>",
      "unique_key": "Q1668353",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136787,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Beta-Glucocerebroside</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a crumpled tissue paper appearance of cell which is a characteristic feature of Gaucher’s disease. It is a sphingolipidoses and the most common lysosomal storage disease and occur due to deficiency of lysosomal enzyme β-glucocerebrosidase. The substrate glucosylceramide gets accumulated in macrophages causing eccentric nucleus.</span></p><p><span style=\"font-size:12.0pt;\">Other clinical features are: Bony pain, pathological fracture, hepatosplenomegaly but no mental retardation (as beta-glucosylceramide is not present in brain).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sphingomyelinase:&nbsp;</strong>Deficiency of this enzyme leads to Niemann-Pick disease, characterized by the accumulation of sphingomyelin in macrophages. Clinical features include hepatosplenomegaly, progressive neurodegeneration, and the presence of foam cells. Niemann-Pick disease often presents with mental retardation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Hexosaminidase:&nbsp;</strong>This enzyme has two forms, A and B. Deficiency of Hexosaminidase A leads to Tay-Sachs disease, characterized by the accumulation of GM2 ganglioside, primarily affecting neurons. Clinical features include progressive neurodegeneration, a cherry-red spot on the macula, and early death. Deficiency of both Hexosaminidase A and B leads to Sandhoff disease, which presents similarly to Tay-Sachs but with additional visceral involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. G-6-phosphatase:&nbsp;</strong>Deficiency of this enzyme leads to Von Gierke’s disease (Glycogen Storage Disease Type I), characterized by impaired glycogenolysis and gluconeogenesis. Clinical features include severe hypoglycemia, lactic acidosis, hepatomegaly, hyperlipidemia, and hyperuricemia. Patients often present with a doll-like facies, protuberant abdomen, and growth retardation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gaucher’s Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-162124.jpg\" alt=\"\" width=\"1000\" height=\"523\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-162347.jpg\" alt=\"\" width=\"1000\" height=\"443\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Harper’s 31<sup>st</sup> ed/pg- 235</strong></span></p>",
      "correct_choice_id": 20082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32323,
      "choices": [
        {
          "id": 129146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Achondroplasia</span></span></span></span></p>"
        },
        {
          "id": 129147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington&rsquo;s disease</span></span></span></span></p>"
        },
        {
          "id": 129148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis</span></span></span></span></p>"
        },
        {
          "id": 129149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following has autosomal recessive pattern of inheritance?&nbsp; (NEET PG 2022)</span></span></span></span></p>",
      "unique_key": "Q3736326",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136805,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Cystic fibrosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis is inherited in an autosomal recessive pattern, which means that an individual needs to inherit two copies of the altered gene (one from each parent) to manifest the condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Achondroplasia:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Achondroplasia is inherited in an autosomal dominant pattern, meaning that having one copy of the altered gene is sufficient to express the condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Huntington&rsquo;s disease:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington&#39;s disease is inherited in an autosomal dominant pattern as well, where one copy of the altered gene is enough to cause the disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial Hypercholesterolemia:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia is typically inherited in an autosomal dominant pattern, but there are rare cases of autosomal recessive inheritance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AD</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Autosomal Dominant)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia</span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington&#39;s disease</span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactose Intolerance</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marfan Syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myotonic Dystrophy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AD Polycystic Kidney Disease</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria Variegate</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AR (Autosomal Recessive)</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ataxia Telangiectasia </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis </span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypertrophic Cardiomyopathy </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle Cell disease </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maple Syrup Urine disease </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homocystinuria </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemochromatosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albinism </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilson&#39;s disease </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemochromatosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AR Polycystic Kidney disease </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Orotic Aciduria </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen Storage Diseases </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All Mucopolysaccharidosis (except Hunter&rsquo;s) </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All sphingolipidosis except <strong>Fabry&rsquo;s disease</strong> </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper&rsquo;s 31<sup>st</sup> ed/pg- 478</span></span></strong></p>",
      "correct_choice_id": 129148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9940,
      "choices": [
        {
          "id": 39726,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris</span></p>"
        },
        {
          "id": 39727,
          "text": "<p><span style=\"font-size:12.0pt;\">Leprosy</span></p>"
        },
        {
          "id": 39728,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 39729,
          "text": "<p><span style=\"font-size:12.0pt;\">Visceral leishmaniasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the given condition:</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture24.jpg\" alt=\"\" width=\"300\" height=\"211\"></p>",
      "unique_key": "Q5036860",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137452,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Pemphigus vulgaris</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given histology image shows a suprabasal blister which points to a diagnosis of Pemphigus Vulgaris.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-182933.jpg\" alt=\"\" width=\"995\" height=\"979\"></span></p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-183030.jpg\" alt=\"\" width=\"1000\" height=\"691\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Leprosy</strong>: Tuberculoid leprosy (paucibacillary) will show granulomatous lesions while lepromatous lesions (multibacillary) shows lipid-laden macrophages (lepra cells) filled with masses (globi) of acid-fast bacilli.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture25.jpg\" alt=\"\" width=\"300\" height=\"228\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycosis fungoides</strong>: Lower portion of the epidermis contains hyperchromatic enlarged lymphocytes. Pautrier’s microabscesses may be seen which are intradermal clusters of atypical lymphoid cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture26.jpg\" alt=\"\" width=\"300\" height=\"218\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Visceral Leishmaniasis</strong>: Visceral Leishmaniasis shows skin lesion with abundant amastigotes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture27.jpg\" alt=\"\" width=\"300\" height=\"239\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris is characterized by suprabasal blisters and a row of tombstone appearance on histology, with a fishnet pattern on direct immunofluorescence due to IgG deposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and cotran pathologic basis of disease 8<sup>th</sup> edition 2307-2308</strong></span></p>",
      "correct_choice_id": 39726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3499,
      "choices": [
        {
          "id": 13975,
          "text": "<p><span style=\"font-size:12.0pt;\">Transmitted by chiggers</span></p>"
        },
        {
          "id": 13976,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphadenopathy is a feature</span></p>"
        },
        {
          "id": 13977,
          "text": "<p><span style=\"font-size:12.0pt;\">Produces NLF producing colonies in MacConkey agar</span></p>"
        },
        {
          "id": 13978,
          "text": "<p><span style=\"font-size:12.0pt;\">Man is an accidental host</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following is true regarding scrub typhus except:</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p>",
      "unique_key": "Q4725134",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Produces NLF producing colonies in MacConkey agar</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Causative organism – Orientia tsutsugamushi (an obligate intracellular Gram-negative bacterium).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>They cannot grow on cell free media</strong>. They are readily cultivated in yolk sac of developing chick embryos. They also grow on mouse fibroblast, HeLa, Hep-2, Detroit 6 and other continuous cell lines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vector - Infected chiggers (trombiculid mite larvae).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Host: A number of small rodents particularly wild rats&nbsp;</strong>of subgenus Rattus are the natural hosts for scrub typhus. <strong>Human infection takes place when man accidentally picks up an infective larval mite while walking, sitting, or lying on the infested ground.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The adult mites have a four-stage lifecycle: egg, larva, nymph and adult.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The larva is the only stage (chigger) that can transmit the disease to humans and other vertebrates,</strong> since the other life stages (nymph and adult) do not feed on vertebrate animals. Both the nymph and the adult are free-living in the soil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Signs and Symptoms- <u>Fever and chills, Headache, Body aches and muscle pain</u>. Dark, scab-like region at the site of the chigger bite (also known as <strong>eschar</strong>). Mental changes, ranging from <u>confusion to coma</u>. <u>Enlarged lymph nodes and rash</u> are also seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis of scrub typhus</strong> that includes enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), immunochromatographic test (ICT), Weil–Felix, polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Transmitted by chiggers</strong>: This is true. Scrub typhus is transmitted by the larvae (chiggers) of trombiculid mites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Lymphadenopathy is a feature</strong>: This is true. Enlarged lymph nodes (lymphadenopathy) are a common feature of scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Man is an accidental host</strong>: This is true. Humans are accidental hosts who become infected when they come into contact with infected chiggers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Orientia tsutsugamushi, the causative agent of scrub typhus, is an obligate intracellular bacterium that cannot grow on cell-free media like MacConkey agar. It requires living cells for its cultivation. Scrub typhus is transmitted by chiggers and features symptoms such as fever, lymphadenopathy, and a characteristic eschar at the site of the bite. Humans are accidental hosts for this infection.</span></p>",
      "correct_choice_id": 13977,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60726,
      "choices": [
        {
          "id": 242197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Age, sex, falls</span></span></span></p>"
        },
        {
          "id": 242198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Age, cough, chronic diarrhoea</span></span></span></p>"
        },
        {
          "id": 242199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Age, fall, confusion </span></span></span></p>"
        },
        {
          "id": 242200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Age, sex, cough, chronic diarrhea</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old lady was brought to the hospital by her daughter, with episodes of falls, confusion, chronic diarrhea, and cough. The intern decided to conduct a geriatric assessment. Which of the following factors indicated such an examination? </span></span></p>",
      "unique_key": "Q6572097",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137458,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Age, fall, confusion.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient&#39;s <strong>age</strong>, history of <strong>falls</strong>, and episodes of <strong>confusion</strong> necessitate a comprehensive geriatric assessment. Falls and cognitive impairment are major indicators of declining functional status in older adults, and age is a key factor in determining the need for such assessments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Comprehensive geriatric assessments include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Age</span></strong><span style=\"font-size:12.0pt\">: Elderly patients are at increased risk of physical and cognitive decline.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">History of falls</span></strong><span style=\"font-size:12.0pt\">: Falls indicate mobility issues, potential frailty, or balance problems.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cognitive changes like confusion</span></strong><span style=\"font-size:12.0pt\">: This may be indicative of underlying neurological issues, delirium, or dementia, warranting a detailed evaluation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Such an assessment helps address potential physical, cognitive, and psychosocial issues, providing a holistic plan for the patient&#39;s care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Age, sex, falls</span></strong><span style=\"font-size:12.0pt\">: While age and falls are relevant, <strong>sex</strong> alone is not a specific indicator for a geriatric assessment. Confusion and cognitive changes carry more significance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Age, cough, chronic diarrhoea</span></strong><span style=\"font-size:12.0pt\">: Cough and chronic diarrhea are not primary indicators for a geriatric assessment. These symptoms may require a focused clinical evaluation but do not necessitate a comprehensive geriatric assessment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Age, sex, cough, chronic diarrhea</span></strong><span style=\"font-size:12.0pt\">: Similar to Option B, while age is relevant, the combination of symptoms here does not directly indicate the need for a geriatric assessment, as the presence of falls and confusion would.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The need for a comprehensive geriatric assessment is primarily indicated by age, history of falls, and cognitive changes (e.g., confusion), as these factors significantly impact the physical and mental well-being of older adults.</span></span></span></p>",
      "correct_choice_id": 242199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9944,
      "choices": [
        {
          "id": 39742,
          "text": "<p><span style=\"font-size:12pt;\">Itraconazole</span></p>"
        },
        {
          "id": 39743,
          "text": "<p><span style=\"font-size:12pt;\">Griseofulvin</span></p>"
        },
        {
          "id": 39744,
          "text": "<p><span style=\"font-size:12pt;\">Terbinafine</span></p>"
        },
        {
          "id": 39745,
          "text": "<p><span style=\"font-size:12pt;\">Voriconazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A drug used to treat Tinea cruris that is experiencing an increasing development of widespread resistance is? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q1197122",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137440,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Terbinafine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Terbinafine&nbsp;</strong>is an antifungal used to treat <strong>Tinea cruris (\"Jock/Dhobi itch\").</strong></span></li><li><span style=\"font-size:12pt;\">Tinea cruris is typically caused by the fungus <strong>Trichophyton rubrum.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Effectiveness&nbsp;</strong>of terbinafine is <strong>compromised</strong> due to <strong>increasing resistance,</strong> especially in <strong>chronic or recurrent infections.</strong></span></li><li><span style=\"font-size:12pt;\">Resistance to terbinafine is associated with <strong>mutations</strong> in the <strong>squalene epoxidase</strong> gene, diminishing the drug’s efficacy.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/whatsapp-image-2023-12-01-at-190431.jpeg\" alt=\"\" width=\"700\" height=\"538\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Squalene epoxidase is vital for <strong>ergosterol synthesis</strong>, crucial for the <strong>fungal cell membrane.</strong></span></li><li><span style=\"font-size:12pt;\">Terbinafine-resistant fungal strains are <strong>cross-resistant</strong> to other squalene epoxidase inhibitors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>NOTE</strong>: Despite resistance to terbinafine, these strains remain <strong>sensitive to azoles</strong> and <strong>other antifungal classes.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Itraconazole:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While Itraconazole is effective against <strong>dermatophytoses,&nbsp;</strong>but there's no specific indication of increasing resistance against it in the context of Tinea cruris.</span></li><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:&nbsp;</strong>Itraconazole inhibits the enzyme <strong>cytochrome P450</strong> <strong>14α-demethylase</strong>, which is necessary for the conversion of <strong>lanosterol to ergosterol </strong>in the fungal cell membrane. This leads to accumulation of toxic intermediates and membrane dysfunction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Griseofulvin:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This drug is used for treatment, but there's no specific indication of increasing resistance against it in the context of Tinea cruris.</span></li><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:&nbsp;</strong>Griseofulvin binds to <strong>tubulin</strong>, disrupting the <strong>microtubule function</strong> and thereby <strong>inhibiting mitosis</strong> in fungal cells. It specifically targets <strong>dividing fungal cells.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Voriconazole:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:&nbsp;</strong>Similar to Itraconazole, Voriconazole also inhibits the <strong>cytochrome P450 </strong>enzyme involved in the production of <strong>ergosterol </strong>for the fungal cell membrane.</span></li><li><span style=\"font-size:12pt;\">It has a <strong>broad spectrum</strong> of antifungal activity. But it is not routinely used for treating superficial fungal infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Terbinafine&nbsp;</strong>is increasingly encountering <strong>resistance</strong> in the treatment of <strong>Tinea cruris</strong>, likely due to <strong>mutations</strong> in the fungal <strong>enzyme squalene epoxidase</strong>, which is the <strong>drug's target</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Online source:</strong></span></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148991/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148991 HYPERLINK \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148991/\"/</u></strong></span></a></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804599/\"><span style=\"font-size:12pt;\"><strong><u>ncbi.nlm.nih.gov - Management of tinea corporis, tinea cruris, and tinea pedis</u></strong></span></a></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047923/\"><span style=\"font-size:12pt;\"><strong><u>ncbi.nlm.nih.gov - Update on terbinafine with a focus on dermatophytoses</u></strong></span></a></p><p><span style=\"font-size:12.0pt;\"><strong>[ijdvl.com - III. Antifungal resistance and treatment options </strong></span><a href=\"https://ijdvl.com/the-unprecedented-epidemic-like-scenario-of-dermatophytosis-in-india-iii-antifungal-resistance-and-treatment-options/\"><span style=\"font-size:12.0pt;\"><strong><u>https://ijdvl.com/the-unprecedented-epidemic-like-scenario-of-dermatophytosis-in-india-iii-antifungal-resistance-and-treatment-options/</u></strong></span></a></p>",
      "correct_choice_id": 39744,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54875,
      "choices": [
        {
          "id": 218961,
          "text": "<p><span style=\"font-size:12.0pt;\">Branched retinal artery occlusion</span></p>"
        },
        {
          "id": 218962,
          "text": "<p><span style=\"font-size:12.0pt;\">Central retinal artery occlusion</span></p>"
        },
        {
          "id": 218963,
          "text": "<p><span style=\"font-size:12.0pt;\">Branched retinal vein occlusion (BRVO)</span></p>"
        },
        {
          "id": 218964,
          "text": "<p><span style=\"font-size:12.0pt;\">Central retinal vein occlusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient of rheumatic heart disease who is noncompliant with treatment presents with complaints of superior field vision loss for the past 1 week. What is the probable cause of the given condition? (INICET MAY 2024)</span></p>",
      "unique_key": "Q7733226",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137442,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Branched retinal vein occlusion (BRVO)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A patient with rheumatic heart disease is at an increased risk of thromboembolic events, which can affect the retinal vessels. The key features presented are a history of superior field vision loss over the past week, which suggests a gradual onset typical of venous occlusion rather than arterial occlusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Features of BRVO:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Gradual onset</strong>: BRVO often presents with gradual vision changes, which is consistent with the patient's history of vision loss over one week.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Superior field vision loss</strong>: Indicates that the inferior retinal quadrant is affected, as retinal involvement typically causes a visual field defect in the opposite quadrant.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Associated with thromboembolic phenomena</strong>: Patients with rheumatic heart disease have a higher risk of thromboembolic events, leading to BRVO.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Branched retinal artery occlusion (BRAO):</strong> BRAO typically presents with a sudden onset of vision loss due to an acute blockage in the retinal artery. It is less common and would present immediately rather than over a week.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Central retinal artery occlusion (CRAO):</strong> CRAO causes a sudden, painless, and profound loss of vision, not a gradual superior field vision loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Central retinal vein occlusion (CRVO)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRVO generally leads to a more severe, diffuse loss of vision, not limited to a specific field. It also typically presents with sudden vision loss rather than the gradual progression described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BRVO is the most probable cause of superior field vision loss in a patient with rheumatic heart disease due to its association with thromboembolic events and gradual onset of symptoms.</span></p>",
      "correct_choice_id": 218963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5053,
      "choices": [
        {
          "id": 20186,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 20187,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 20188,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
        },
        {
          "id": 20189,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A known patient of tuberculosis, on INH for the past 3 months complains of numbness, tingling and burning sensation in all the extremities. What could be vitamin deficiency?(NEET PG 2022)</span></p>",
      "unique_key": "Q3771499",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136792,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin B6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct answer. Isoniazid (INH) can lead to a deficiency in Vitamin B6. Peripheral neuropathy, which includes symptoms like numbness, tingling, and burning sensations in the extremities, is a common side effect of Vitamin B6 deficiency. Therefore, the patient's symptoms are likely a result of this deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Vitamin B12 (Cobalamin) Deficiency:</strong> Vitamin B12 deficiency can also cause neuropathy and neurological symptoms, but it's less likely to be associated with INH use specifically. However, it's essential to consider Vitamin B12 levels in tuberculosis patients, as they may have dietary restrictions or other factors that could lead to this deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Vitamin B1 (Thiamine) Deficiency:&nbsp;</strong>Vitamin B1 deficiency can cause a condition called beriberi, which can include neurological symptoms. However, INH is not known to directly cause Vitamin B1 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Vitamin B3 (Niacin) Deficiency:&nbsp;</strong>Niacin deficiency can lead to a condition called pellagra, which includes skin issues and neurological symptoms. INH can indirectly affect niacin levels, but it's not a common cause of niacin deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Isoniazid inhibits&nbsp;pyridoxal phosphokinase which is required for synthesis of<strong> </strong>biologically active form of pyridoxine (B6) i.e. pyridoxal phosphate. Thus, isoniazid inhibits the formation of the active form of&nbsp;<strong>B<sub>6</sub></strong>.</span></li><li><span style=\"font-size:12.0pt;\">As Vit. B6 (PLP) is required for niacin (B<sub>3</sub>) synthesis from tryptophan, hence isoniazid therapy also causes Niacin deficiency.</span></li><li><span style=\"font-size:12.0pt;\">In this question, best answer to mark is B<sub>6</sub> as INH directly inhibits B<sub>6 </sub>formation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Dinesh Puri 3<sup>rd</sup> ed/pg-371</strong></span></p>",
      "correct_choice_id": 20186,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32317,
      "choices": [
        {
          "id": 129122,
          "text": "<p><span style=\"font-size:12.0pt;\">GM-1 ganglioside receptor</span></p>"
        },
        {
          "id": 129123,
          "text": "<p><span style=\"font-size:12.0pt;\">GM-2 ganglioside receptor</span></p>"
        },
        {
          "id": 129124,
          "text": "<p><span style=\"font-size:12.0pt;\">GM-3 ganglioside receptor</span></p>"
        },
        {
          "id": 129125,
          "text": "<p><span style=\"font-size:12.0pt;\">GD-1a ganglioside receptor</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rice water diarrhoea, intoxication is due to which ganglioside?(NEET PG &nbsp;2022)</span></p>",
      "unique_key": "Q1222552",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136800,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) GM-1 ganglioside receptor.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rice water diarrhea is a characteristic symptom of cholera, which is caused by the bacterium Vibrio cholerae. The toxin produced by Vibrio cholerae is the cholera toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cholera toxin binds to the GM-1 ganglioside receptor on the surface of intestinal epithelial cells. This binding leads to the activation of adenylate cyclase, increased levels of cyclic AMP (cAMP), and subsequent secretion of water and electrolytes into the intestinal lumen, resulting in the characteristic rice water diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. GM-2 ganglioside receptor:&nbsp;</strong>GM-2 ganglioside is not related to cholera toxin binding. Instead, it is involved in diseases like Tay-Sachs and Sandhoff disease, where there is a deficiency in the enzyme hexosaminidase, leading to the accumulation of GM-2 ganglioside.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. GM-3 ganglioside receptor:&nbsp;</strong>GM-3 ganglioside is not involved in the mechanism of cholera toxin. It is a simpler ganglioside involved in different cellular processes but not specifically in the pathology of cholera.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>D. GD-1a ganglioside receptor:&nbsp;</strong></span><span style=\"font-size:12pt;\">GD-1a ganglioside is not associated with the cholera toxin. It has roles in neural cell function and development but does not play a part in the mechanism of action of cholera toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Cholera toxin binds to the GM-1 ganglioside receptor on intestinal epithelial cells, causing the characteristic rice water diarrhea by increasing cyclic AMP levels and promoting water and electrolyte secretion into the intestinal lumen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 202</strong></span></p>",
      "correct_choice_id": 129122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20929,
      "choices": [
        {
          "id": 83680,
          "text": "<p>Low calcium</p>"
        },
        {
          "id": 83681,
          "text": "<p>Defective collagen formation</p>"
        },
        {
          "id": 83682,
          "text": "<p>Inhibition of clotting factors</p>"
        },
        {
          "id": 83683,
          "text": "<p>Increased keratinization of epithelium</p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\">A patient presenting with bleeding gums and easy bruisability was diagnosed with scurvy. What is the biochemical basis of scurvy?(NEET PG 2023)</p>",
      "unique_key": "Q5709822",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136778,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Ans. B) Defective collagen formation</strong></p><p>&nbsp;</p><p>Scurvy is a condition caused by a deficiency of vitamin C (ascorbic acid), which is essential for the hydroxylation of proline and lysine residues in the synthesis of collagen. Collagen is a crucial protein for the structural integrity of connective tissues, including blood vessels, skin, and gums. In the absence of sufficient vitamin C, collagen synthesis is impaired, leading to weakened blood vessels, bleeding gums, and easy bruising..</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A.&nbsp;</strong>Low calcium levels do not cause scurvy; they may contribute to other clinical conditions like Muscle cramps and stiffness, Tingling and Numbness, Tetany.</p><p>&nbsp;</p><p><strong>Option C.&nbsp;</strong>Vitamin K deficiency leads to the inhibition of clotting factors and cause bleeding tendencies.</p><p>&nbsp;</p><p><strong>Option D.&nbsp;</strong>Vitamin A deficiency causes hyperkeratosis and epithelial changes, such as xerosis and Bitot's spots, and night blindness.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-092725.jpg\" alt=\"\" width=\"1000\" height=\"869\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture20.jpg\" alt=\"\" width=\"700\" height=\"160\"></p>",
      "correct_choice_id": 83681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32318,
      "choices": [
        {
          "id": 129126,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits NM receptor</span></p>"
        },
        {
          "id": 129127,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits reuptake of acetyl choline</span></p>"
        },
        {
          "id": 129128,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits release of acetylcholine from lower motor neurons</span></p>"
        },
        {
          "id": 129129,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits synthesis of acetyl choline</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mechanism of action of botulinum toxin is:(NEET PG 2022)</span></p>",
      "unique_key": "Q6974655",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136801,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Inhibits release of acetylcholine from lower motor neurons</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct mechanism of action. Botulinum toxin works by blocking the release of acetylcholine, a neurotransmitter, from lower motor neurons. This inhibition prevents the transmission of nerve signals to muscle cells, leading to muscle paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Inhibits NM receptor:</strong> Botulinum toxin does not directly inhibit the neuromuscular (NM) receptor. Instead, it affects the neuromuscular junction but not by inhibiting the receptor itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Inhibits reuptake of acetylcholine:</strong> Botulinum toxin does not inhibit the reuptake of acetylcholine. Its primary mode of action is different.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Inhibits synthesis of acetylcholine:</strong> Botulinum toxin does not inhibit the synthesis of acetylcholine. It mainly interferes with the release and function of acetylcholine at the neuromuscular junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Botulinum toxin, produced by the bacterium Clostridium botulinum, exerts its mechanism of action by preventing the release of acetylcholine at the neuromuscular junction. The toxin cleaves specific proteins involved in vesicle fusion and neurotransmitter release, leading to the inhibition of acetylcholine release from lower motor neurons. This blockade of acetylcholine release results in muscle paralysis, making botulinum toxin useful for medical and cosmetic purposes to treat conditions characterized by excessive muscle activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 587</strong></span></p>",
      "correct_choice_id": 129128,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4950,
      "choices": [
        {
          "id": 19774,
          "text": "<p><span style=\"font-size:12.0pt;\">Fumaryl acetoacetate hydrolase</span></p>"
        },
        {
          "id": 19775,
          "text": "<p><span style=\"font-size:12.0pt;\">Di Hydroxy Phenyl Acetate Dioxygenase</span></p>"
        },
        {
          "id": 19776,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisate Dehydrogenase</span></p>"
        },
        {
          "id": 19777,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenyl alanine hydroxylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old patient presented with dark urine, which further blackens on exposure to air. What’s the enzyme defect in this case?(NEET PG 2021)</span></p>",
      "unique_key": "Q3089672",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136815,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Di Hydroxy Phenyl Acetate Dioxygenase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a case of alkaptonuria which is an inborn error in catabolism of tyrosine and phenylalanine. Enzyme deficient is Homogentisate Dioxygenase or Di-Hydroxy Phenyl Acetate Dioxygenase. The IUPAC name of homogentisate is 2,5-Dihydroxy Phenyl Acetate. The older name of this enzyme was Homogentisate oxidase. (not Homogentisate Dehydrogenase).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fumaryl acetoacetate hydrolase</strong>:</span></p><ul><li><span style=\"font-size:12.0pt;\">Fumaryl acetoacetate hydrolase is an enzyme involved in the breakdown of tyrosine, an amino acid. Deficiency of this enzyme leads to Tyrosinemia Type I. However, Tyrosinemia Type I does not cause darkening of urine upon exposure to air.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Homogentisate Dehydrogenase</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Homogentisate oxidase, (not Homogentisate Dehydrogenase) is the enzyme responsible for the metabolism of homogentisic acid. Deficiency of this enzyme leads to Alkaptonuria. In Alkaptonuria, homogentisic acid accumulates and causes the urine to turn black upon exposure to air. This is due to the oxidation of homogentisic acid.</span><br>&nbsp;</li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenylalanine hydroxylase</strong>:</span></p><ul><li><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase is an enzyme involved in the metabolism of phenylalanine, another amino acid. Deficiency of this enzyme leads to Phenylketonuria (PKU). PKU does not directly lead to darkening of urine upon exposure to air.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In alkaptonuria patients, fresh urine is normal in color, but on standing it turns black due to oxidation of excess homogentisic acid. Homogentisic acid is an intermediate in the catabolism of Tyrosine. For complete list of phenyalanine and tyrosine catabolism defects, refer to topic aromatic amino acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 286</strong></span></p>",
      "correct_choice_id": 19775,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5042,
      "choices": [
        {
          "id": 20142,
          "text": "<p><span style=\"font-size:12.0pt;\">Uroporphyrinogen III synthase</span></p>"
        },
        {
          "id": 20143,
          "text": "<p><span style=\"font-size:12.0pt;\">Uroporphyrinogen I Synthase</span></p>"
        },
        {
          "id": 20144,
          "text": "<p><span style=\"font-size:12.0pt;\">ALA synthase</span></p>"
        },
        {
          "id": 20145,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferrochelatase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A paint factory worker working since 20 years complains of joint pain, insomnia, fatigue, constipation, headache. He is found to have anemia. Enzyme affected is? (NEET PG 2022)</span></p>",
      "unique_key": "Q1690304",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136789,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ferrochelatase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This enzyme is crucial in the final step of heme synthesis, where it inserts iron into protoporphyrin to form heme. In lead poisoning, ferrochelatase is inhibited, leading to decreased heme production, increased ALA production, and symptoms such as anemia, fatigue, and other neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Uroporphyrinogen III synthase:&nbsp;</strong>This enzyme is involved in heme synthesis. Lead poisoning can disrupt heme synthesis, but Uroporphyrinogen III synthase is not the primary enzyme affected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Uroporphyrinogen I Synthase:&nbsp;</strong>Similar to Uroporphyrinogen III synthase, this enzyme is involved in heme synthesis. Lead poisoning can disrupt heme synthesis, but Uroporphyrinogen I Synthase is not the primary enzyme affected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>ALA synthase (Aminolevulinic acid synthase):&nbsp;</strong>It is a key enzyme in the heme synthesis pathway. Lead poisoning increase activity of ALA synthase. In lead poisoning, product inhibition by heme is&nbsp; reduced leading to the accumulation of ALA and its precursor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The reference of paint factory worker indicates that it is a case of lead poisoning. Lead affects two enzymes of Heme synthesis pathway:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">PBG synthase (another name ALA dehydratase)</span></li><li><span style=\"font-size:12.0pt;\">Ferrochelatase (last enzyme of heme synthesis and adds Fe to its substrate)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The defect in any of these enzymes will lead to decrease in haem synthesis resulting in anemia. So, the answer in this case is Ferrochelatase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 306-307</strong></span></p>",
      "correct_choice_id": 20145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32291,
      "choices": [
        {
          "id": 129022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nutritional rickets </span></span></span></span></p>"
        },
        {
          "id": 129023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked hypophosphatemic rickets </span></span></span></span></p>"
        },
        {
          "id": 129024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D dependent rickets type I </span></span></span></span></p>"
        },
        {
          "id": 129025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D dependent rickets type II</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old boy presented with developmental delay, recurrent chest infections and worsening bony pain. His serum PTH was normal. Calcium was normal and phosphate was low. There is no response to Vitamin D. The probable diagnosis is:(NEET PG 2021)</span></span></span></span></p>",
      "unique_key": "Q3333338",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136818,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) X-linked hypophosphatemic rickets</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked hypophosphatemic rickets is a genetic disorder characterized by low phosphate levels in the blood due to impaired phosphate reabsorption by the kidneys. This condition can lead to bone deformities, bony pain, and growth delays. Normal PTH levels are consistent with this diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Nutritional rickets</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nutritional rickets is typically caused by a deficiency of Vitamin D, calcium, or phosphate. In this case, the boy has normal serum PTH, which suggests that his body is not compensating for a Vitamin D deficiency. Additionally, his phosphate levels are low despite Vitamin D supplementation, which is not characteristic of nutritional rickets.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Vitamin D dependent rickets type I</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is caused by a genetic mutation that impairs the conversion of Vitamin D to its active form. It usually presents with low calcium levels and elevated PTH, which is not in line with the boy&#39;s normal PTH levels.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Vitamin D dependent rickets type II</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D dependent rickets type II is another genetic disorder that affects the body&#39;s response to Vitamin D. It can lead to low calcium levels and elevated PTH, which do not match the boy&#39;s normal PTH levels.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></u></strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked hypophosphatemic rickets is a genetic disorder that results in low phosphate levels and can present with bony pain, developmental delay, and recurrent infections. It is distinct from other forms of rickets due to its genetic basis and the characteristic low phosphate levels in the absence of Vitamin D response.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- https://www.ncbi.nlm.nih.gov/books/NBK562285/ </span></span></strong></p>",
      "correct_choice_id": 129023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32674,
      "choices": [
        {
          "id": 130546,
          "text": "<p><span style=\"font-size:12.0pt;\">Cephalin</span></p>"
        },
        {
          "id": 130547,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelin</span></p>"
        },
        {
          "id": 130548,
          "text": "<p><span style=\"font-size:12.0pt;\">Lecithin</span></p>"
        },
        {
          "id": 130549,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiolipin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Respiratory distress syndrome is caused by the deficiency of?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q6572447",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136785,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Lecithin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Specifically phosphatidylcholine, is a major component of pulmonary surfactant. Surfactant plays a crucial role in reducing surface tension in the alveoli of the lungs, preventing their collapse. A deficiency in lecithin can contribute to respiratory distress syndrome, especially in premature infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cephalin:&nbsp;</strong>Cephalin is a type of phospholipid, and while it is present in cell membranes, it is not a major component of pulmonary surfactant and is not directly associated with respiratory distress syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sphingomyelin:&nbsp;</strong>Sphingomyelin is another type of phospholipid found in cell membranes. The deficiency to recycle this lipid due to defective lysosomal enzyme sphingomyelinase cause sphingolipidoses also known as Niemann Pick disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cardiolipin:&nbsp;</strong>Cardiolipin is a phospholipid found in the inner mitochondrial membrane and bacterial membranes. The disease associated with cardiolipins are anti-phospholipid syndrome and Barth syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">RDS is a common condition in premature infants due to inadequate surfactant production, particularly the deficiency of lecithin. The educational objective is to understand the etiology of RDS and its association with surfactant components, specifically lecithin. This knowledge is crucial for healthcare professionals involved in the care of neonates, as RDS can have serious respiratory consequences in premature infants and requires appropriate management and support.</span></p>",
      "correct_choice_id": 130548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20942,
      "choices": [
        {
          "id": 83732,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
        },
        {
          "id": 83733,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
        },
        {
          "id": 83734,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurler syndrome</span></p>"
        },
        {
          "id": 83735,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with mental retardation, bone pain, and inability to walk. On fundoscopy examination, a cherry red spot is seen. There is no organomegaly. What is the most likely diagnosis?&nbsp; (</span>NEET PG 2023)</p>",
      "unique_key": "Q9435894",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136783,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tay-Sachs disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tay-Sachs disease. </strong>The given clinical scenario, along with the fundoscopy image showing a macular cherry-red spot, indicates that the most likely diagnosis is Tay-Sachs disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Niemann-Pick disease</strong>: Niemann-Pick disease is another lysosomal storage disorder, but it often presents with hepatosplenomegaly (enlarged liver and spleen), which is not mentioned in the case. The cherry-red spot is not a typical feature of Niemann-Pick disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Hurler syndrome</strong> (mucopolysaccharidosis I), autosomal recessive condition that affects multiple organs. Enzyme deficient is α-L-Iduronidase. Presents usually at 6-24 months with clouded cornea, coarse facial features, joint stiffness, and skeletal dysplasia. Glaucoma, retinal degeneration, and nasal discharge are the other features. The condition is generally fatal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gaucher’s Disease</strong> presents with bone pain, hepatosplenomegaly, and trephine biopsy showing a cell with a characteristic crumpled tissue paper appearance. Mental Retardation is not seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-093730.jpg\" alt=\"\" width=\"1000\" height=\"839\"></p>",
      "correct_choice_id": 83732,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5037,
      "choices": [
        {
          "id": 20122,
          "text": "<p><span style=\"font-size:12.0pt;\">Histone</span></p>"
        },
        {
          "id": 20123,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycoprotein</span></p>"
        },
        {
          "id": 20124,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleic acid</span></p>"
        },
        {
          "id": 20125,
          "text": "<p><span style=\"font-size:12.0pt;\">Helicases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">DNA packing is done by?</span>(NEET PG 2022)</p>",
      "unique_key": "Q8177466",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136788,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Histone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histones are proteins responsible for DNA packaging. The DNA wraps around histones, forming a structure called a nucleosome. Histones are positively charged proteins that interact with the negatively charged DNA, allowing for efficient packaging and compaction of DNA strands. This packaging is essential for the organization of DNA within the cell nucleus and its regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Glycoprotein:&nbsp;</strong>Glycoproteins are not directly involved in DNA packaging. They are molecules composed of a protein and a carbohydrate moiety. While glycoproteins have various functions in the cell, they do not play a role in the compaction and organization of DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Nucleic acid:&nbsp;</strong>DNA itself is a type of nucleic acid. DNA molecules are composed of nucleotides and serve as the genetic material of cells. DNA molecules do not package themselves; instead, they interact with histones and other proteins to undergo packaging and compaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Helicases:&nbsp;</strong>Helicases are enzymes responsible for unwinding and separating the DNA strands during processes such as DNA replication and transcription. They do not participate in DNA packaging; instead, their role is to facilitate the access of various cellular machinery to the DNA template.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Nucleosomes = DNA + Histone proteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histone proteins are rich in basic AA such as lysine and arginine, so, carry a positive charge. While DNA due to PO<sub>4</sub><sup>2-</sup> groups has large negative charge. So, in nucleosomes, DNA and histones are tightly packed due to interaction between these opposite charges.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture12.jpg\" alt=\"\" width=\"500\" height=\"258\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 351</strong></span></p>",
      "correct_choice_id": 20122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20940,
      "choices": [
        {
          "id": 83724,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 83725,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine</span></p>"
        },
        {
          "id": 83726,
          "text": "<p><span style=\"font-size:12.0pt;\">Biotin</span></p>"
        },
        {
          "id": 83727,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiamine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A child presents with thinning of hair and scaling of the scalp. On taking further history, it is found that she consumes raw eggs in her diet regularly. The given manifestations are due to the deficiency of which of the following vitamins?(NEET PG 2023)</span></p>",
      "unique_key": "Q7042067",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136782,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Biotin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Biotin (Vitamin B7): The given clinical vignette of scaling of scalp and alopecia as well as the history of raw egg consumption suggests biotin deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Raw egg white contains avidin, which tightly binds to biotin and renders it unabsorbable from the intestine. Hence, there can be a biotin deficiency state. Biotin deficiency is known to cause hair thinning and scalp scaling, among other symptoms related to the skin and hair. Biotin is essential for healthy skin, hair, and nails.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A.</strong>&nbsp;<strong>Niacin (Vitamin B3):</strong> Niacin deficiency can lead to a condition known as pellagra, which primarily presents with symptoms such as dermatitis, diarrhea, and dementia. Thinning hair and scaling of the scalp are not typical features of niacin deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B.</strong>&nbsp;<strong>Pyridoxine (Vitamin B6):</strong> Pyridoxine deficiency can result in various neurological symptoms and skin changes, but it doesn't typically manifest as thinning hair and scaling of the scalp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D.</strong>&nbsp;<strong>Thiamine (Vitamin B1):</strong> Thiamine deficiency can lead to conditions like beriberi and Wernicke-Korsakoff syndrome, but it does not typically present with hair and scalp issues like thinning and scaling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-093702.jpg\" alt=\"\" width=\"1000\" height=\"593\"></p>",
      "correct_choice_id": 83726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20930,
      "choices": [
        {
          "id": 83684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of lipoprotein lipase</span></span></span></span></p>"
        },
        {
          "id": 83685,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of glycogen synthase</span></span></span></span></p>"
        },
        {
          "id": 83686,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of phosphofructokinase 1</span></span></span></span></p>"
        },
        {
          "id": 83687,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of hormone-sensitive lipase</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is seen in low insulin: glucagon ratio?(NEET PG 2023)</span></span></span></span></p>",
      "unique_key": "Q1987620",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136779,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Activation of hormone-sensitive lipase</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a fasting state, insulin decreases and glucagon increases, hence there is Low insulin: glucagon ratio. Since insulin has an inhibitory effect on hormone-sensitive lipase, low insulin: glucagon ratio results in the activation of hormone-sensitive lipase.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of lipoprotein lipase (LPL) is promoted by insulin, but here it is low. Lipoprotein lipase enzyme breaks triglycerides (TGs) of Lipoproteins (Chylomicrons and VLDL) to give 3 fatty acids and glycerol.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of glycogen synthase is promoted by insulin (fed state). In low insulin: glucagon ratio, glycogen synthase activity will be reduced, leading to decreased glycogenesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of phosphoructokinase-1 (PFK1) is promoted by insulin (fed state). PFK1 is a rate-regulating enzyme in glycolysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone-sensitive lipase is present inside the cells of adipose tissues. Stored triglycerides in adipose tissues are broken by HSL into 3 fatty acids and glycerol. 3 fatty acids go in blood and then are taken by liver where &beta;- Oxidation of fatty acids (catabolic) occurs to give energy in Liver.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In diabetic patients, low insulin level which causes an increase in HSL activity, promoting the breakdown of lipids and the release of FFAs from adipose tissue. HSL activity is accelerated by hormones like epinephrine, norepinephrine, glucagon, ACTH, TSH, GH, ADH, and melanocyte-stimulating hormones (MSH).</span></span></p>",
      "correct_choice_id": 83687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13931,
      "choices": [
        {
          "id": 55685,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate lobe of liver</span></p>"
        },
        {
          "id": 55686,
          "text": "<p><span style=\"font-size:12.0pt;\">Duodenum</span></p>"
        },
        {
          "id": 55687,
          "text": "<p><span style=\"font-size:12.0pt;\">Lesser omentum</span></p>"
        },
        {
          "id": 55688,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior vena cava</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The Para-sagittal section of the abdomen is given below. What is the superior border of the structure marked A?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-124506.png\" alt=\"\" width=\"200\" height=\"260\"></p>",
      "unique_key": "Q9840742",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137450,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Caudate lobe of liver</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epiploic foramen is the structure indicated in the provided image. The caudate lobe of the liver forms the superior boundary of the epiploic foramen, also known as the foramen of Winslow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epiploic foramen is a vertical slit of about 3 cm behind the free right border of the lesser omentum. It connects the lesser sac to the greater sac. The pearl summarizes the various relations of the foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-81_yINZyAs.jpg\" alt=\"\" width=\"600\" height=\"496\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The caudate lobe is a small lobe of the liver situated on the posterior aspect, between the sulcus for the vena cava on the right and the fissure for the ligamentum venosum on the left. The caudate lobe forms the superior border of the epiploic foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Duodenum</strong>: The duodenum is the first part of the small intestine immediately beyond the stomach. While the duodenum is closely related to the epiploic foramen, specifically the posterior surface of its first part, it does not form the superior border. Instead, it comprises the posterior boundary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Lesser omentum</strong>: The lesser omentum is a double layer of peritoneum that extends from the liver to the lesser curvature of the stomach and the start of the duodenum. The free edge of the lesser omentum contains the bile duct, hepatic artery, and portal vein, forming the anterior border of the epiploic foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Inferior vena cava</strong>: The inferior vena cava (IVC) is a large vein that carries deoxygenated blood from the lower and middle body into the right atrium of the heart. It is located posteriorly to the epiploic foramen but does not form the superior border. It creates the posterior boundary, similar to the duodenum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The epiploic foramen, also known as the foramen of Winslow, is a key anatomical passage within the abdominal cavity that connects the greater sac to the lesser sac.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The caudate lobe of the liver forms the superior border of this foramen.</span></p>",
      "correct_choice_id": 55685,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9848,
      "choices": [
        {
          "id": 39358,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Transfusion reaction</span></span></span></p>"
        },
        {
          "id": 39359,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute adrenal crisis</span></span></span></p>"
        },
        {
          "id": 39360,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Fat embolism</span></span></span></p>"
        },
        {
          "id": 39361,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hemorrhagic shock</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A 24-year-old man met with an road traffic accident and was brought to the casualty after 6 hours. His B.P. was 90/60 mm Hg, heart rate was 110/min, and Sp02 was 92%. A blood transfusion was done. After a few hours, the patient is febrile, tachypneic, and starts bleeding from the IV and NG tube sites. His SpO2 levels started falling. What could be the cause? (AIIMS MAY 2020)</span></span></span></p>",
      "unique_key": "Q3021124",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137432,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Transfusion reaction</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Given the clinical scenario the most likely diagnosis is acute hemolytic transfusion reaction causing DIC (disseminated intravascular coagulation) resulting in bleeding from IV catheter and nasogastric tube within a few hours of blood transfusion.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute Hemolytic Transfusion reaction</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Immune-mediated hemolysis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Preformed antibodies</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> in recipient lyse donor erythrocytes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Complement-mediated lysis occurs causing <strong>intravascular hemolysis and hemoglobinuria</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Severe cases, tissue factor released from the lysed erythrocytes may <strong>initiate DIC</strong>, which is a consumptive coagulopathy with bleeding manifestations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other complications include <strong>shock, acute kidney injury, and sometimes, death.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The various blood transfusion reactions according to their time of occurrence are as follows:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Anaphylactic reaction</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> - Within a few seconds to minutes of the transfusion. Common in <strong>selective IgA deficiency patients.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Allergic/Urticarial reactions - Within 2-3 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute hemolytic transfusion reaction (AHTR) - Within 24 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Febrile <strong>non-hemolytic</strong> transfusion reaction (FNHT) - Within 6 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Delayed hemolytic transfusion reaction (DHTR) - After 24 hours of transfusion</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong>TRALI vs TACO:</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-132115.png\" style=\"height:429px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">TRALI: transfusion-related acute lung injury, TACO: Transfusion-associated cardiac overload, CXR: chest X-ray, BNP: B type natriuretic peptide, PAOP: pulmonary artery occluding pressure.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Acute adrenal crisis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition involves sudden adrenal insufficiency, leading to hypotension, shock, and electrolyte imbalances. It would not typically cause the specific symptoms of hemolysis and DIC seen in this case.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fat embolism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Fat embolism syndrome can occur after long bone fractures, presenting with respiratory distress, neurological symptoms, and petechiae. However, it typically occurs within 24-72 hours after injury and is not directly associated with blood transfusions.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hemorrhagic shock</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Hemorrhagic shock results from significant blood loss, leading to hypotension and tachycardia. While this could be a consideration, the transfusion reaction and subsequent DIC better explain the patient&#39;s clinical presentation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An acute hemolytic transfusion reaction (AHTR) can lead to disseminated intravascular coagulation (DIC), characterized by rapid onset of fever, bleeding from multiple sites, and hemolysis shortly after a blood transfusion.</span></span></span></p>",
      "correct_choice_id": 39358,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32315,
      "choices": [
        {
          "id": 129114,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 129115,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B</span></p>"
        },
        {
          "id": 129116,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        },
        {
          "id": 129117,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Condition shown below is due to which vitamin deficiency?(NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture15.jpg\" alt=\"\" width=\"300\" height=\"195\"></span></p>",
      "unique_key": "Q3375294",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136799,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is Bitot’s spot shown in the picture due to vitamin A deficiency. There is build-up of keratin located superficially in conjunctiva. This can be oval, triangular or irregular in shape. This is also associated with conjunctival xerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Vitamin B:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin B is a group of vitamins that includes B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folate), and B12 (cobalamin). These vitamins play various roles in energy production, brain function, and cell metabolism</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>Deficiencies in different B vitamins can result in a range of symptoms, including fatigue, neurological issues, anemia, and skin problems.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Vitamin C:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin C is essential for the synthesis of collagen, wound healing, and the absorption of iron from plant-based foods. It also acts as an antioxidant, protecting cells from damage.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>A lack of vitamin C can lead to scurvy, which includes symptoms such as bleeding gums, joint pain, and skin issues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Vitamin K:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin K is crucial for blood clotting and bone health. It helps in the synthesis of proteins involved in clot formation and bone mineralization.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>Vitamin K deficiency can result in bleeding disorders and weakened bones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin A plays a vital role in the growth and development of human cells, controlling the immune system by preventing infections, and activating white blood cells</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>Vitamin A deficiency can lead to night blindness, dry skin, poor immune function, and impaired growth and development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 530</strong></span></p>",
      "correct_choice_id": 129114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6651,
      "choices": [
        {
          "id": 26573,
          "text": "<p><span style=\"font-size:12.0pt;\">Paranoid personality disorder</span></p>"
        },
        {
          "id": 26574,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizoid personality disorder</span></p>"
        },
        {
          "id": 26575,
          "text": "<p><span style=\"font-size:12.0pt;\">Antisocial personality disorder</span></p>"
        },
        {
          "id": 26576,
          "text": "<p><span style=\"font-size:12.0pt;\">Emotionally unstable personality disorder</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young male who is shy and prefers social isolation appears to be emotionally cold and resides alone. There is no history of hallucinations or delusions. The most likely diagnosis is: (</span>INICET May 2020)</p>",
      "unique_key": "Q4790523",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137439,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Schizoid personality disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schizoid personality disorder is marked by <strong>detachment from social relationships</strong> and a restricted range of emotional expression. Individuals prefer <strong>solitude</strong> and appear <strong>emotionally cold.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Paranoid personality disorder:&nbsp;</strong>It is characterized by <strong>excessive suspiciousness</strong> and distrust of others. They may be <strong>excessively sensitive </strong>and give <strong>excessive importance to themselves</strong>. The vignette described above does not mention suspiciousness, infact mentions there is no history of delusions. Hence the answer is not paranoid personality disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Antisocial personality disorder:&nbsp;</strong>These patients disregard others' rights and frequently violates them. They frequently get involved in unlawful behaviours such as theft, conning etc.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Emotionally unstable personality disorder:&nbsp;</strong>Otherwise known as Borderline personality disorder. They are almost always in the state of crisis. They have a history of <strong>unstable relationships and emotions</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schizoid personality disorder is characterized by <strong>detachment</strong> from social relationships and prefer <strong>solitary activities</strong>. They are <strong>emotionally cold</strong> and are indifferent to praise or criticism. There is also an <strong>absence of close relationships</strong>. It is classified as Cluster A personality disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 746.</strong></span></p>",
      "correct_choice_id": 26574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4898,
      "choices": [
        {
          "id": 19567,
          "text": "<p><span style=\"font-size:12.0pt;\">Dietary Glucose</span></p>"
        },
        {
          "id": 19568,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic Gluconeogenesis</span></p>"
        },
        {
          "id": 19569,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic Glycogenolysis</span></p>"
        },
        {
          "id": 19570,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle glycogenolysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person had a meal at 8 pm and records blood glucose at 7 am on the next day. What’s the source of glucose in this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q4092834",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136806,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hepatic Glycogenolysis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hepatic glycogenolysis involves the breakdown of glycogen stored in the liver into glucose. This process provides source of blood glucose for 12-18 hours, So By 7 am the next day, liver's glycogen stores is the main source of blood glucose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dietary Glucose: </strong>Dietary glucose from the previous evening's meal would have been absorbed and utilized or stored shortly after eating. By 7 am the next day, the influence of dietary glucose on blood glucose levels would have diminished significantly. It is unlikely to be the primary source of the elevated glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hepatic Gluconeogenesis: </strong>Hepatic gluconeogenesis is the process by which the liver produces glucose from non-carbohydrate precursors, such as amino acids and glycerol. During overnight fasting, the liver actively engages in gluconeogenesis to maintain blood glucose levels. It happens mainly only after 18 hours or more of fasting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Muscle Glycogenolysis: </strong>Muscle glycogenolysis primarily supplies glucose for use within muscle tissue itself and is not a major contributor to blood glucose levels during fasting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The person is fasting for last 11 hours. First source of blood glucose is dietary (food) glucose that can provide glucose for upto 2 hours after meals (option a is excluded).&nbsp; After that liver glycogenolysis will start and is able to maintain blood glucose for next 12-18 hours of fasting (option c is answer).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hepatic gluconeogenesis will start only after liver glycogen is exhausted i.e. only after 12 hours onwards (option b is wrong answer).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Muscle glycogen cannot maintain blood glucose as the end-product of muscle glycogenolysis is glucose 6-phosphate due to absence of enzyme glucose 6-phosphatase in muscle (option D is wrong answer). This enzyme is only present in liver cell’s ER and is used to convert glucose 6-phosphate to free glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>- Harper 31<sup>st</sup> e/pg. 176</strong></span></p>",
      "correct_choice_id": 19569,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14897,
      "choices": [
        {
          "id": 59548,
          "text": "<p><span style=\"font-size:16px;\">Pain on passive stretch</span></p>"
        },
        {
          "id": 59549,
          "text": "<p><span style=\"font-size:16px;\">Paralysis</span></p>"
        },
        {
          "id": 59550,
          "text": "<p><span style=\"font-size:16px;\">Pallor</span></p>"
        },
        {
          "id": 59551,
          "text": "<p><span style=\"font-size:16px;\">Pulselessness</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">The last symptoms to develop in compartment syndrome is: (INICET MAY 2021)</span></p>",
      "unique_key": "Q5110858",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137447,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"margin-left:0cm;text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Pulselessness</strong></span></p><p style=\"margin-left:0cm;text-align:justify;\">&nbsp;</p><p style=\"margin-left:0cm;text-align:justify;\"><span style=\"font-size:16px;\"><strong>COMPARTMENT SYNDROME</strong></span></p><p style=\"margin-left:0cm;text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">In acute compartment syndrome, <strong>increased pressure in a close fascial space</strong> causes loss of microcirculation.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Most commonly</strong> compartment syndrome involves <strong>deep posterior compartment of leg &gt; deep flexor compartment of forearm</strong> <strong>(commonest in children).</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">It is most commonly seen following fractures of supracondylar humerus and tibia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Clinical Features:</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The diagnosis of compartment syndrome is based on dramatically increasing pain (out of proportion to injury) after fracture/any injury (1st symptom) not even getting relieved on analgesics.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Pain</strong> and <strong>resistance on passive stretch</strong> (Distal most joint of extremity) – <strong>1st sign</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Pulselessness</strong> is a <strong>late feature</strong> and it is not a reliable indicator of compartment syndrome. The presence of pulse does not exclude the diagnosis.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>In later stages, paresthesia and paralysis</strong> ensue due to nerve involvement.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Acute compartment syndrome presents with the following 5 Ps:</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20193108.jpg\" width=\"1262\" height=\"500\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Paralysis</strong> and <strong>Pulselessness</strong> are considered late and ominous signs, indicating severe and irreversible tissue damage.&nbsp;</span></li><li><span style=\"font-size:16px;\">Paralysis and pulselessness signifies that the condition has progressed significantly, indicating permanent injury.</span></li><li><span style=\"font-size:16px;\">Pulselessness generally represents a more critical and terminal stage of circulatory compromise.</span></li><li><span style=\"font-size:16px;\">It implies complete or near-complete cessation of blood flow, which is ultimately the most severe and final physiological sign of impending tissue death.</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A. Pain on passive stretch.&nbsp;</strong>Pain and resistance to the passive stretch is the first sign of the compartment syndrome.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B. Paralysis.&nbsp;</strong>Paralysis occurs in the late stages of the syndrome due to involvement of the nerves.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C. Pallor.&nbsp;</strong>Pallor appears in the late stages and indicates irreversible muscle and nerve ischemia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The last sign/symptom to appear in a compartment syndrome is pulselessness, as it signifies the most advanced stage of vascular compromise.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">While paralysis is also very late, the absence of a pulse is a definitive sign of severe, critical ischemia.</span></p></li></ul>",
      "correct_choice_id": 59551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4926,
      "choices": [
        {
          "id": 19679,
          "text": "<p><span style=\"font-size:12.0pt;\">Lipoprotein lipase deficiency</span></p>"
        },
        {
          "id": 19680,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia</span></p>"
        },
        {
          "id": 19681,
          "text": "<p><span style=\"font-size:12.0pt;\">Tangier’s disease</span></p>"
        },
        {
          "id": 93758,
          "text": "<p><span style=\"font-size:12.0pt;\">Huntington’s disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has multiple tendon xanthomas. Serum cholesterol (398 mg/dl) &amp; LDL (220 mg/dl) were found to be raised. Statins were given to this patient. What is the diagnosis? (NEET PG 2021)</span></p>",
      "unique_key": "Q5942956",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136811,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Familial hypercholesterolemia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia (FH) is a genetic disorder characterized by significantly elevated levels of LDL cholesterol in the blood. Tendon xanthomas are a common feature of FH. Statins are commonly prescribed to lower LDL cholesterol levels in FH patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lipoprotein lipase deficiency: </strong>Lipoprotein lipase deficiency is a different condition that affects the breakdown of triglycerides in lipoproteins, not cholesterol metabolism. It does not typically present with tendon xanthomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tangier's disease: </strong>Tangier's disease is a rare genetic disorder that leads to very low levels of high-density lipoprotein (HDL) cholesterol. It does not typically present with elevated LDL cholesterol levels or tendon xanthomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Huntington's disease: </strong>Huntington's disease is a neurological disorder and is not related to cholesterol metabolism or tendon xanthomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All of the conditions i.e. tendon xanthomas, high serum cholesterol and LDL levels and statin therapy which is given to inhibit rate limiting enzyme HMG CoA reductase of cholesterol biosynthesis indicate that cholesterol is raised in this patient. So, the most probable diagnosis is Familial hypercholesterolemia aka Type IIa hyperlipoproteinemia that occur due to deficiency of LDL receptor on liver or Apo B100 mutation<strong>.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lipoprotein lipase deficiency or Apo C- II defect cause familial hyperchylomicronemia or Type I <strong>hyperlipoproteinemia</strong> with raised plasma chylomicrons and TG levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Tangier’s disease, there is defect in ABCA1 receptors causing low levels of plasma HDL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 258</strong></span></p>",
      "correct_choice_id": 19680,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54650,
      "choices": [
        {
          "id": 218065,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin pinch</span></p>"
        },
        {
          "id": 218066,
          "text": "<p><span style=\"font-size:12.0pt;\">Sunken eyeballs</span></p>"
        },
        {
          "id": 218067,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output, Thirst &amp; oral mucosa</span></p>"
        },
        {
          "id": 218068,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent tears</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the best indicator of some dehydration in SAM? (INICET MAY 2024)</span></p>",
      "unique_key": "Q8184580",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Urine output, Thirst &amp; oral mucosa</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe Acute Malnutrition (SAM) in children can present as either Kwashiorkor or Marasmus. These conditions cause the child to appear very thin and emaciated, making it challenging to rely on typical physical signs like skin pinch or sunken eyeballs for dehydration assessment. SAM children, especially those with Marasmus, already have a \"baggy pant\" appearance and very thin skin, making these signs unreliable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most reliable indicator of dehydration in SAM children is assessing urine output, thirst and the condition of the oral mucosa:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">⁠Urine output, thirst: If the child eagerly drinks water, it indicates some dehydration. Refusal to drink or feed may suggest severe dehydration.</span></li><li><span style=\"font-size:12.0pt;\">⁠Oral mucosa: Checking the dryness of the oral mucosa is a practical and reliable method. In SAM children, if the oral mucosa is dry, it indicates dehydration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Skin pinch:</strong> This option is incorrect because SAM children already have very thin skin, making skin pinch an unreliable indicator.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sunken eyeballs</strong>: This option is incorrect as SAM children naturally have sunken eyeballs due to severe weight loss and malnutrition, making this sign unreliable for detecting dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Absent tears</strong>: this indicator is not the best indicator. It can be seen in some as well as severe dehydration cases.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In SAM children, the best indicators of dehydration are urine output, the dryness of the oral mucosa and the child's thirst.</span></p>",
      "correct_choice_id": 218067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20933,
      "choices": [
        {
          "id": 83696,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria</span></span></span></span></p>"
        },
        {
          "id": 83697,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria</span></span></span></span></p>"
        },
        {
          "id": 83698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homocystinuria</span></span></span></span></p>"
        },
        {
          "id": 83699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maple syrup urine disease</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infant is brought by his parents with complaints that his urine turns black on standing. Which of the following metabolic disorders is likely?&nbsp;</span></span></span></span>(NEET PG 2023)</p>",
      "unique_key": "Q7902948",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136780,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Alkaptonuria</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OPTION B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Blackening of urine on standing is characteristic feature of alkaptonuria.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-092946.jpg\" style=\"height:529px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-093120.jpg\" style=\"height:523px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/picture21_4bnP46i.jpg\" style=\"height:355px; width:700px\" /></p>",
      "correct_choice_id": 83697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54678,
      "choices": [
        {
          "id": 218177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Fastrach</span></span></span></p>"
        },
        {
          "id": 218178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Flexible</span></span></span></p>"
        },
        {
          "id": 218179,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Proseal</span></span></span></p>"
        },
        {
          "id": 218180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AMBU LMA</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the 2nd generation supraglottic airway device from the options given below. (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q3173135",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137438,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) LMA Proseal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The LMA Proseal is a second-generation supraglottic airway device. Second-generation devices are designed to be safer than first-generation devices, offering a higher pressure pharyngeal seal and a reduced risk of aspiration. These devices often have two tubes: one for ventilation (airway tube) and another for draining gastric secretions (gastric tube). The LMA Proseal, specifically, features these characteristics, making it a second-generation device.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-105259.png\" style=\"height:417px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. LMA Fastrach:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> LMA Fastrach, also known as the intubating LMA, is not categorized as either a first or second-generation device. It is classified as a special LMA due to its unique design, which facilitates difficult intubations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/010.jpg\" style=\"height:476px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. LMA Flexible:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The LMA Flexible is a variant of the LMA Classic, which is a first-generation device. It has a flexible airway tube but lacks the features of second-generation devices, such as a high-pressure pharyngeal seal and an additional tube for gastric drainage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-105323.png\" style=\"height:283px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Ambu LMA:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The Ambu LMA does not have the dual-tube system that characterizes second-generation devices.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-105328.png\" style=\"height:210px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LMA Proseal is a second-generation supraglottic airway device, identified by its two-tube system that enhances safety by reducing the risk of aspiration</span></span></span></p>",
      "correct_choice_id": 218179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4904,
      "choices": [
        {
          "id": 19591,
          "text": "<p><span style=\"font-size:12.0pt;\">E1: Pyruvate dehydrogenase E2: Dihydrolipoyl Transacetylase</span></p>"
        },
        {
          "id": 19592,
          "text": "<p><span style=\"font-size:12.0pt;\">E1: Pyruvate Decarboxylase E2: Dihydrolipoyl dehydrogenase</span></p>"
        },
        {
          "id": 19593,
          "text": "<p><span style=\"font-size:12.0pt;\">E1: Pyruvate carboxylase E2: Dihydrolipoyl Transacetylase</span></p>"
        },
        {
          "id": 19594,
          "text": "<p><span style=\"font-size:12.0pt;\">E1: Pyruvate dehydrogenase E2: Dihydrolipoyl dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">This multienzyme complex converts Pyruvate to Acetyl CoA. Identify E1 and E2:&nbsp;(NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-180124.jpg\" alt=\"\" width=\"300\" height=\"194\"></p><p style=\"text-align:justify;\">&nbsp;</p>",
      "unique_key": "Q1020786",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136808,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) E1: Pyruvate dehydrogenase E2: Dihydrolipoyl Transacetylase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation<u>:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The provided images depict the components and functioning of the pyruvate dehydrogenase complex, a key multienzyme complex in the metabolic pathway that converts pyruvate into acetyl-CoA, an essential step linking glycolysis to the citric acid cycle. This complex requires vitamins B1, B2, B3, B5, and lipoic acid as cofactors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Table: Components of PDH complex and their roles</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-180521.jpg\" alt=\"\" width=\"1000\" height=\"349\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pyruvate Decarboxylase and Dihydrolipoyl dehydrogenase:&nbsp;</strong>Incorrect as Pyruvate Decarboxylase is not involved in the conversion of pyruvate to acetyl-CoA in this context, and Dihydrolipoyl dehydrogenase is the E3 component of the complex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pyruvate carboxylase and Dihydrolipoyl Transacetylase:&nbsp;</strong>Incorrect because Pyruvate carboxylase is involved in a different metabolic pathway (gluconeogenesis), not in the conversion of pyruvate to acetyl-CoA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Pyruvate dehydrogenase and Dihydrolipoyl dehydrogenase:&nbsp;</strong>Incorrect as the second enzyme is E3 in this complex, not E2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture2.jpg\" alt=\"\" width=\"1000\" height=\"413\"></u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref-Harper 31<sup>st</sup> e/pg. 162</strong></span></p>",
      "correct_choice_id": 19591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32675,
      "choices": [
        {
          "id": 130550,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 130551,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        },
        {
          "id": 130552,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        },
        {
          "id": 130553,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the vitamin deficiency:&nbsp;(NEET PG 2023)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/picture23.jpg\" alt=\"\" width=\"300\" height=\"219\"></p>",
      "unique_key": "Q2058536",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136786,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin D The image show Bowing of the legs, a condition known as bowlegs or genu varum, is commonly associated with Vitamin D deficiency, especially in children. Vitamin D plays a crucial role in the regulation of calcium and phosphorus, essential minerals for bone health. Deficiency of Vitamin D can lead to improper mineralization of bones, resulting in deformities such as bowing of the legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Vitamin A:&nbsp;</strong>Vitamin A deficiency is not typically associated with bowing of the legs. However, severe vitamin A deficiency cause night blindness and other eye menifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B3 (Niacin):&nbsp;</strong>Vitamin B3 deficiency can cause pellagra, which involves skin, gastrointestinal, and neurological symptoms. It is not directly linked to bowing of the legs.</span></p><p>&nbsp;</p><p><strong>Option D.</strong><span style=\"font-size:14.6667px;\">&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Vitamin B1 (Thiamine):&nbsp;</strong></span><span style=\"font-size:12pt;\">Vitamin B1 deficiency can lead to beriberi, a condition that primarily affects the cardiovascular and nervous systems. It is not a common cause of bowing of the legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Vitamin D</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-093829.jpg\" alt=\"\" width=\"1000\" height=\"752\"></p>",
      "correct_choice_id": 130551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43947,
      "choices": [
        {
          "id": 175451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interferon gamma</span></span></span></p>"
        },
        {
          "id": 175452,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complement 5a protein</span></span></span></p>"
        },
        {
          "id": 175453,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histamine</span></span></span></p>"
        },
        {
          "id": 175454,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prostaglandin</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with fever, cough, weight loss, histology of the pathology is as shown below. What is the most likely cytokine involved? (INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151657.JPG\" style=\"height:256px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2741770",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137451,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Interferon gamma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IFN-</span><span dir=\"ltr\" lang=\"EL\" style=\"font-size:12.0pt\">&gamma; </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is crucial in the immune response against intracellular pathogens, including the activation of macrophages and the formation of granulomas, as seen in tuberculosis and other granulomatous diseases. It is produced primarily by T-helper cells (Th1) and is critical for orchestrating the cellular immune response that results in the granuloma formation evident in the provided histology.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Complement 5a protein</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory process, enhancing the immune response by attracting immune cells to sites of infection, but not directly involved in granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Histamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A mediator in allergic reactions, involved in vasodilation and increased vascular permeability, not typically associated with chronic inflammatory or granulomatous responses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Prostaglandin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These are lipid compounds that mediate inflammation. Like histamine, they are more often associated with immediate inflammatory responses and pain, rather than chronic inflammation or granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interferon gamma is key in managing intracellular infections and is responsible for the activation of macrophages and other immune cells that culminate in granuloma formation, a central feature in controlling persistent pathogens such as those seen in tuberculosis.</span></span></span></p>",
      "correct_choice_id": 175451,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4918,
      "choices": [
        {
          "id": 19647,
          "text": "<p><span style=\"font-size:12.0pt;\">Cysteine</span></p>"
        },
        {
          "id": 19648,
          "text": "<p><span style=\"font-size:12.0pt;\">Methionine</span></p>"
        },
        {
          "id": 19649,
          "text": "<p><span style=\"font-size:12.0pt;\">Serine</span></p>"
        },
        {
          "id": 19650,
          "text": "<p><span style=\"font-size:12.0pt;\">Homocysteine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following Amino acid needs to be supplied in the diet of patients with Cystathionine beta synthase defect?&nbsp;</span><span style=\"font-size:11pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q9884034",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136810,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cysteine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cysteine is not typically restricted in the diet of patients with CBS deficiency. In fact, cysteine supplementation may be necessary in some cases because CBS deficiency can lead to a decreased ability to convert homocysteine into cysteine. However, this decision is made on an individual basis after assessing the patient's specific needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Methionine: </strong>Methionine is usually restricted in the diet of patients with CBS deficiency. Since methionine is metabolized to homocysteine, limiting dietary methionine intake can help reduce homocysteine levels in these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serine: </strong>Serine is not typically restricted in the diet of CBS-deficient patients. It is not directly related to homocysteine metabolism, so it does not require special dietary adjustments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Homocysteine: </strong>Homocysteine is not supplied in the diet but rather accumulates in the body as a result of CBS deficiency. Managing and reducing elevated homocysteine levels is the primary goal of treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cystathionine beta synthase (CBS) is involved in the synthesis of cysteine from dietary methionine. Cysteine synthesis require methionine, serine and vitamin B6. The reactions are summarized in the diagram:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:500/793;width:35.81%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture3.jpg\" alt=\"\" width=\"500\" height=\"793\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, in case of CBS deficiency there will be no formation of cystathionine and cysteine. so, cysteine becomes essential and needs to be taken in diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 291</strong></span></p>",
      "correct_choice_id": 19647,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4911,
      "choices": [
        {
          "id": 19619,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiamine</span></p>"
        },
        {
          "id": 19620,
          "text": "<p><span style=\"font-size:12.0pt;\">Riboflavin</span></p>"
        },
        {
          "id": 19621,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 19622,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old Farmer on maize diet with diarrhoea, dementia, and dermatitis. Which Vitamin is deficient in this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q5311376",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136809,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Niacin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Niacin deficiency, specifically pellagra, is characterized by the \"3 Ds\": dermatitis (skin changes), diarrhea (digestive symptoms), and dementia (neurological symptoms). The symptoms described in the patient match those of pellagra, making niacin deficiency the likely cause.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thiamine: </strong>Thiamine deficiency, also known as beriberi, primarily manifests as neurological and cardiovascular symptoms. It is not associated with dermatitis and diarrhea, which are prominent features of pellagra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Riboflavin: </strong>Riboflavin deficiency, also known as ariboflavinosis, can lead to various symptoms, including sore throat, redness and swelling of the lining of the mouth and throat, and inflammation and redness of the tongue (magenta tongue). While it shares some symptoms with pellagra, such as mucous membrane changes, it does not typically cause dementia and diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pyridoxine: </strong>Pyridoxine deficiency, also known as vitamin B6 deficiency, can lead to neurological symptoms but does not typically cause dermatitis or diarrhea. It is not the primary deficiency associated with the symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The major protein of Maize, “Zein” lacks tryptophan which is required for Niacin biosynthesis. 60 mg of tryptophan gives 1 mg of Niacin in the body. So, pellagra is more common when maize is the staple diet due to decreased synthesis of Niacin. Pellagra is characterized by 3Ds i.e. diarrhoea, dementia and dermatitis. Death and delirium and depression can also occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pellagra can also be caused due to Isoniazid therapy as isoniazid inhibits PLP (B6) formation which in turn is required for Niacin synthesis. Vitamin B2 is also required for Niacin synthesis, so, a deficiency either of B2 or B6 or both can cause pellagra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiamine (B1) deficiency leads to Beri-Beri. CNS and CVS are affected in dry Beri-Beri and wet Beri-Beri respectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Main symptoms of Riboflavin deficiency are Cheilosis, Glossitis and Corneal vascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyridoxine deficiency cause anemia (microcytic, hypochromic) and seizures in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 534-535</strong></span></p>",
      "correct_choice_id": 19621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20928,
      "choices": [
        {
          "id": 83676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency</span></span></span></span></p>"
        },
        {
          "id": 83677,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zinc deficiency</span></span></span></span></p>"
        },
        {
          "id": 83678,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium deficiency</span></span></span></span></p>"
        },
        {
          "id": 83679,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper deficiency</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with erythematous scaly patches in the perioral region, mucosal ulcers, and impaired epithelial wound healing. What is the likely mineral deficiency associated with this condition?(NEET PG 2023)</span></span></span></span></p>",
      "unique_key": "Q3649360",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136777,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Zinc deficiency</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features of periorificial dermatitis and stomatitis in a young child are suggestive of acrodermatitis enteropathica, seen in zinc deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture19.jpg\" style=\"height:335px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Iron deficiency -</strong> Most common micronutrient deficiency globally. It presents with iron-deficiency anemia. It presents clinically with pallor, fatigue, weakness, shortness of breath, light-headedness.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calcium deficiency -</strong> Leads to rickets in children. Apart from clinical vignette of rickets there can be Muscle cramps and stiffness, Tingling and Numbness, Tetany.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Copper deficiency -</strong> Leads to anemia, growth retardation, defective keratinization and pigmentation of hair, hypothermia, degenerative changes in aortic elastin, osteopenia, and neurological symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zinc deficiency disorder- Acrodermatitis enteropathica</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-092648.jpg\" style=\"height:462px; width:1000px\" /></p>",
      "correct_choice_id": 83677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6952,
      "choices": [
        {
          "id": 27776,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
        },
        {
          "id": 27777,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-c 4-d</span></p>"
        },
        {
          "id": 27778,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-d, 3-b 4-c</span></p>"
        },
        {
          "id": 27779,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following molecules with their carriers in plasma: (</span>INICET Nov 2022)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/12.jpg\" alt=\"\" width=\"1000\" height=\"590\"></span></p>",
      "unique_key": "Q4858325",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1-b, 2-c, 3-d, 4-a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plasma contains various components like ions, inorganic and organic molecules that help in the transport of substances across various parts of the body, such as Albumin, globulin, and fibrinogen fractions.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Thyroxine</strong> is carried by transthyretin, also called thyroid-binding pre-albumin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fatty acids</strong> are carried by albumin, which is a major carrier protein and osmotic regulator. It also transports hormones, amino acids, vitamins, and steroids.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hemoglobin</strong> binds to haptoglobin, which prevents free hemoglobin from being excreted in the urine.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Heme</strong> binds with hemopexin for heme recycling.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plasma transporters like prealbumin, albumin, haptoglobin, and hemopexin play crucial roles in the transport and recycling of thyroxine, fatty acids, hemoglobin, and heme respectively.</span></p>",
      "correct_choice_id": 27776,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3675,
      "choices": [
        {
          "id": 14679,
          "text": "<p><span style=\"font-size:12.0pt;\">Seminiferous tubule</span></p>"
        },
        {
          "id": 14680,
          "text": "<p><span style=\"font-size:12.0pt;\">Area postrema</span></p>"
        },
        {
          "id": 14681,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve</span></p>"
        },
        {
          "id": 14682,
          "text": "<p><span style=\"font-size:12.0pt;\">Loop of Henle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an immunologically privileged site?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">NOV 2018)</span></p>",
      "unique_key": "Q7639501",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Seminiferous tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The seminiferous tubules are an immunologically privileged site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sites with immune privilege are anatomical regions that are naturally less subject to immune responses than most other areas of the body. So, an allograft can be placed in these sites without endangering a rejection reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other examples:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anterior chamber of the eye</span></li><li><span style=\"font-size:12.0pt;\">Cornea</span></li><li><span style=\"font-size:12.0pt;\">Testes</span></li><li><span style=\"font-size:12.0pt;\">Brain except at area postrema where blood brain barrier is absent</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Area postrema:</strong> This region of the brain lacks the blood-brain barrier and is not considered an immunologically privileged site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Optic nerve:</strong> While the optic nerve is part of the central nervous system, it is not classified as an immunologically privileged site like the brain or anterior chamber of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Loop of Henle:</strong> This structure is part of the kidney's nephron and is not considered an immunologically privileged site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The seminiferous tubules are an immunologically privileged site, protecting developing sperm from immune system attack.</span></p>",
      "correct_choice_id": 14679,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23173,
      "choices": [
        {
          "id": 92655,
          "text": "<p><span style=\"font-size:12.0pt;\">Mercedes-Benz sign</span></p>"
        },
        {
          "id": 92656,
          "text": "<p><span style=\"font-size:12.0pt;\">Gall bladder polyp</span></p>"
        },
        {
          "id": 92657,
          "text": "<p><span style=\"font-size:12.0pt;\">Gall bladder cancer</span></p>"
        },
        {
          "id": 92658,
          "text": "<p><span style=\"font-size:12.0pt;\">Phrygian cap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the finding in the given ultrasound image. (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/14/whatsapp-image-2023-06-12-at-190121011010201026_page_5.jpg\" alt=\"\" width=\"300\" height=\"233\"></span></p>",
      "unique_key": "Q9309375",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137457,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Phrygian cap</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phrygian caps&nbsp;are the most common congenital&nbsp;anatomic variant of the&nbsp;gallbladder.&nbsp;It denotes folding of the fundus back upon the gallbladder body and is asymptomatic with no pathological significance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a normal anatomical variant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mercedes-Benz sign:</strong> This sign is typically associated with pneumobilia, or air within the biliary tree, often seen in cases of fistula between the intestine and bile ducts or after certain surgical procedures. It is characterized by radiolucent branching structures that resemble the Mercedes-Benz logo, which is not evident in this ultrasound image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gall bladder polyp:</strong> Polyps would appear as echogenic masses attached to the gallbladder wall. They are usually well-defined and can vary in size. The image does not display any such formations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gall bladder cancer:</strong> This would generally appear as irregular, often thickened masses within the gallbladder, potentially with more heterogeneous echotexture compared to the surrounding liver tissue. This ultrasound does not show features typical of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Phrygian cap is the most common congenital anatomic variant of the gallbladder, appearing as a fold at the gallbladder fundus. It is asymptomatic and has no pathological significance, important to recognize in imaging to differentiate it from potential abnormalities.</span></p>",
      "correct_choice_id": 92658,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32313,
      "choices": [
        {
          "id": 129106,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop codon mutation</span></p>"
        },
        {
          "id": 129107,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-sense mutation</span></p>"
        },
        {
          "id": 129108,
          "text": "<p><span style=\"font-size:12.0pt;\">Mis sense Mutation</span></p>"
        },
        {
          "id": 129109,
          "text": "<p><span style=\"font-size:12.0pt;\">Silent Mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When a codon is changed to stop codon, then it is: (NEET PG 2022)</span></p>",
      "unique_key": "Q8946662",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136798,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Non-sense mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amino acid codon is replaced by a stop codon causing premature termination of translation and truncated protein</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Stop Codons mutation:&nbsp;</strong>There are specific codons known as \"stop codons\" that signal the termination of protein synthesis. These stop codons include UAA, UAG, and UGA. When a ribosome encounters a stop codon, it releases the newly synthesized protein, and protein synthesis comes to an end.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Mis-sense mutation:&nbsp;</strong>Codon for one amino acid is replaced by another amino acid codon causing change in protein properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Silent mutation:&nbsp;</strong>Codon is changed but<strong> </strong>amino acid is not changed due to codon degeneracy, so no effect on resulting protein<strong>.&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture14_ty2kqQF.jpg\" alt=\"\" width=\"500\" height=\"282\"></u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 396</strong></span></p>",
      "correct_choice_id": 129107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5084,
      "choices": [
        {
          "id": 20309,
          "text": "<p>HMP pathway</p>"
        },
        {
          "id": 20310,
          "text": "<p>Glycolysis</p>"
        },
        {
          "id": 20311,
          "text": "<p>Gluconeogenesis</p>"
        },
        {
          "id": 20312,
          "text": "<p>Kreb cycle</p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A Mediterranean person receive primaquine. Which pathway is affected by G-6-PD enzyme deficiency?(NEET PG 2022)</span></p>",
      "unique_key": "Q7166776",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136796,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) HMP pathway</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is the correct pathway affected by G6PD enzyme deficiency. G6PD is an enzyme crucial for the proper functioning of the HMP pathway. Deficiency in G6PD can lead to hemolysis (breakdown of red blood cells) in response to oxidative stress, as the HMP pathway is responsible for generating reducing equivalents (NADPH) necessary to protect cells from oxidative damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B</strong>.&nbsp;<strong>Glycolysis:&nbsp;</strong>G6PD deficiency primarily affects the HMP pathway, not glycolysis. Glycolysis is a separate metabolic pathway involved in the breakdown of glucose for energy production.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C</strong>.&nbsp;<strong>Gluconeogenesis:&nbsp;</strong>G6PD deficiency does not directly affect gluconeogenesis. Gluconeogenesis is the metabolic pathway responsible for producing glucose from non-carbohydrate sources, and it does not rely on the G6PD enzyme.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D</strong>.&nbsp;<strong>Krebs cycle:&nbsp;</strong>G6PD deficiency does not directly affect the Krebs cycle (also known as the citric acid cycle or TCA cycle). The Krebs cycle is involved in the oxidative metabolism of acetyl-CoA, and G6PD deficiency primarily impacts the earlier steps of glucose metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">G6PD is the first and rate limiting enzyme of HMP pathway which is the major source of NADPH that is required for reduced glutathione generation and help reduce oxidative stress by neutralizing free radicals.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Primaquine is an antimalarial drug and causes oxidative stress. In patients with <strong>Glucose-6-Phosphate Dehydrogenase (</strong>G6PD) deficiency, primaquine can cause hemolysis so it is avoided.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 182</strong></span></p>",
      "correct_choice_id": 20309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5069,
      "choices": [
        {
          "id": 20249,
          "text": "<p><span style=\"font-size:12.0pt;\">Makes cancer cells immortal</span></p>"
        },
        {
          "id": 20250,
          "text": "<p><span style=\"font-size:12.0pt;\">Aerobic glycolysis with lactate formation</span></p>"
        },
        {
          "id": 20251,
          "text": "<p><span style=\"font-size:12.0pt;\">Produce more ATP</span></p>"
        },
        {
          "id": 20252,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease glucose uptake</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about Warburg effect?(NEET PG 2022)</span></p>",
      "unique_key": "Q7542221",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136795,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Aerobic glycolysis with lactate formation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct statement. The Warburg effect is characterized by cancer cells utilizing glycolysis even in the presence of oxygen (aerobic glycolysis), leading to the production of lactate. This metabolic shift is a hallmark of many cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Makes cancer cells immortal:&nbsp;</strong>This statement is not true. The Warburg effect is a metabolic phenomenon observed in many cancer cells where they preferentially use glycolysis to generate energy, but it does not make cancer cells immortal. Immortality of cancer cells is typically associated with mutations that allow them to evade normal cell cycle regulation and apoptosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Produce more ATP:&nbsp;</strong>This statement is not true in the context of the Warburg effect. While glycolysis is less efficient at producing ATP compared to oxidative phosphorylation (which occurs in the mitochondria), cancer cells under the Warburg effect primarily generate ATP through glycolysis, which is less efficient but provides other metabolic advantages to rapidly dividing cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Decrease glucose uptake:</strong> This statement is not true. Cancer cells under the Warburg effect often increase their glucose uptake to meet their high energy demands through glycolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Warburg effect</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This effect occurs in cancerous cells. This is a paradox from normal in the sense that Cancer cells convert&nbsp;pyruvate to lactate&nbsp;even in the presence of O<sub>2</sub>. This is known as<strong>&nbsp;aerobic glycolysis.</strong></span></li><li><span style=\"font-size:12.0pt;\">Energy derived from conversion of pyruvate to lactate is just<strong>&nbsp;2 ATPs</strong>, hence rapidly growing cancer cells take up large amount of glucose compared to normal cells. Due to large amount of glucose used, patients have Cachexia (weight loss).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 30th ed/pg- 738</strong></span></p>",
      "correct_choice_id": 20250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32320,
      "choices": [
        {
          "id": 129134,
          "text": "<p><span style=\"font-size:12.0pt;\">Carnitine</span></p>"
        },
        {
          "id": 129135,
          "text": "<p><span style=\"font-size:12.0pt;\">Acyl carrier protein</span></p>"
        },
        {
          "id": 129136,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol transporter</span></p>"
        },
        {
          "id": 129137,
          "text": "<p><span style=\"font-size:12.0pt;\">LCAT</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fatty acid transport through mitochondrial membrane is via?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q4064438",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136802,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Carnitine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carnitine plays a crucial role in the transport of long-chain fatty acids across the inner mitochondrial membrane for subsequent beta-oxidation. It forms a complex with fatty acids, allowing them to enter the mitochondria.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Fatty acid transport into mitochondria from cytoplasm involve the carnitine shuttle system using enzymes Carnitine Palmitoyl Transferase-I (CPT-I) and CPT-II. CPT-I is RLE of fatty acid transport or beta-oxidation of fatty acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture16.jpg\" alt=\"\" width=\"500\" height=\"430\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Acyl carrier protein:</strong> Acyl carrier proteins are involved in fatty acid synthesis rather than transport across the mitochondrial membrane. They are essential components of fatty acid biosynthesis pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Cholesterol transporter:</strong> Cholesterol transporters primarily facilitate the transport of cholesterol, not fatty acids, across cellular membranes. They are not directly involved in fatty acid transport into mitochondria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>LCAT (Lecithin-Cholesterol Acyltransferase):</strong> LCAT is an enzyme responsible for esterifying cholesterol, and it does not play a role in fatty acid transport across the mitochondrial membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fatty acid transport through the mitochondrial membrane involves the carnitine shuttle system. Long-chain fatty acids are activated to form fatty acyl-CoA in the cytoplasm. Carnitine acyltransferase I (CAT I) then catalyzes the transfer of the acyl group from CoA to carnitine, forming fatty acyl-carnitine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fatty acyl-carnitine is transported across the mitochondrial membrane via a carnitine-acylcarnitine translocase.Once inside the mitochondrial matrix, carnitine acyltransferase II (CAT II) catalyzes the transfer of the acyl group back to CoA, allowing the fatty acid to undergo β-oxidation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 208</strong></span></p>",
      "correct_choice_id": 129134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4963,
      "choices": [
        {
          "id": 19826,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratosis pilaris rubra</span></p>"
        },
        {
          "id": 19827,
          "text": "<p><span style=\"font-size:12.0pt;\">Eczema</span></p>"
        },
        {
          "id": 19828,
          "text": "<p><span style=\"font-size:12.0pt;\">Phrynoderma</span></p>"
        },
        {
          "id": 19829,
          "text": "<p><span style=\"font-size:12.0pt;\">Icthyosis&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Night blindness history, corneal drying and patient has Bitot’s spots. Which of the following is found in this patient?&nbsp;(NEET PG 2021)</span></p>",
      "unique_key": "Q4843137",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136817,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Phrynoderma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The symptoms of patient clearly indicate vitamin A deficiency. One of the other clinical feature of vitamin A deficiency is follicular hyperkeratosis aka Phrynoderma which is characterized by excessive keratinization of certain area of body such as elbows and knees. Vitamin A prevents hyperkeratinization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture7.jpg\" alt=\"\" width=\"600\" height=\"196\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Keratosis pilaris rubra</strong>: Keratosis pilaris rubra is a skin condition characterized by the appearance of small, red bumps on the skin, often on the arms and thighs. It primarily affects the skin and does not directly relate to the symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Eczema</strong>: Eczema is a chronic skin condition characterized by red, itchy, and inflamed skin patches. While eczema can affect the skin, it is not associated with night blindness, corneal drying, or Bitot's spots.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Ichthyosis</strong>: Ichthyosis is a group of genetic skin disorders that lead to dry, scaly, and thickened skin. It primarily affects the skin's texture and is not commonly associated with night blindness and corneal drying.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms of night blindness, corneal drying, and Bitot's spots, are indications of vitamin A deficiency. Phrynoderma, which is characterized by goosebump-like skin changes, is a manifestation of severe vitamin A deficiency and is the most relevant option in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Dinesh Puri 3<sup>rd</sup> e/pg. 393,&nbsp;</strong></span></p>",
      "correct_choice_id": 19828,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5983,
      "choices": [
        {
          "id": 23902,
          "text": "<p><span style=\"font-size:12pt;\">Formalin</span></p>"
        },
        {
          "id": 23903,
          "text": "<p><span style=\"font-size:12pt;\">Air dried</span></p>"
        },
        {
          "id": 23904,
          "text": "<p><span style=\"font-size:12pt;\">Normal saline</span></p>"
        },
        {
          "id": 23905,
          "text": "<p><span style=\"font-size:12pt;\">95% ethanol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the fixative used for a pap smear?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q6641651",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137434,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 95% ethanol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most common fixative used in a Pap smear is 95% ethyl alcohol (ethanol). This fixative helps preserve the cells collected on the slides for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Formalin:</strong> Formalin (10%) is commonly used as a fixative for histology specimens but is not used for Pap smears.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Air dried:</strong> Air drying is not a method used for preserving Pap smear specimens as it can lead to poor preservation of cellular details.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Normal saline:</strong> Normal saline is not a fixative. Tissues must be immediately transferred to formol saline if using normal saline temporarily.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The fixative used for a Pap smear is typically 95% ethanol, which helps preserve the cellular details on the slides for accurate cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23905,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54536,
      "choices": [
        {
          "id": 217613,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
        },
        {
          "id": 217614,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 217615,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphoma</span></span></span></p>"
        },
        {
          "id": 217616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcoma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most likely tumor arising from the slide shown in the image?&nbsp;</span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/23/whatsapp-image-2024-08-23-at-10620-pm-2.jpeg\" style=\"height:269px; width:300px\" /></p>",
      "unique_key": "Q3300240",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137444,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Adenocarcinoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The provided histopathological image shows multiple gland formations, which is characteristic of adenocarcinoma. Adenocarcinomas are malignant tumors that arise from glandular epithelial cells. The presence of glandular structures in the histological slide is a key indicator of this type of cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Squamous cell carcinoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This type of carcinoma is characterized by the presence of keratin pearls and intercellular bridges, which are not seen in the provided image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Lymphoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Lymphomas are malignancies of the lymphoid tissue and do not typically show glandular patterns in histology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sarcoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sarcomas arise from mesenchymal cells and are characterized by spindle-shaped cells. They do not exhibit glandular formations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma is identified by the presence of glandular formations in histopathological slides.</span></span></span></p>",
      "correct_choice_id": 217614,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4930,
      "choices": [
        {
          "id": 19694,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 phosphatase</span></p>"
        },
        {
          "id": 19695,
          "text": "<p><span style=\"font-size:12.0pt;\">Gluco-Cerebrosidase</span></p>"
        },
        {
          "id": 19696,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase A</span></p>"
        },
        {
          "id": 19697,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-Galactosidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with weakness, anemia, bony pain &amp; hepatosplenomegaly. A histological picture is shown with cells in bone marrow. Which of the following enzyme is deficient?(NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture4.jpg\" alt=\"\" width=\"300\" height=\"246\"></span></p>",
      "unique_key": "Q8491590",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136812,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gluco-Cerebrosidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The picture show macrophages with typical crumpled tissue paper appearance/ wrinkled appearance that is highly characteristic of Gaucher’s disease (most common lysosomal storage disease). Glucocerebrosides accumulate in reticuloendothelial system due to deficiency of enzyme β-Glucocerebrosidase. These patients have bony pain, pathological fractures, hepatosplenomegaly, but no mental retardation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Glucose 6 phosphatase: </strong>Deficiency of Glucose 6 phosphatase is associated with Glycogen Storage Disease Type I (GSD-I) or von Gierke disease. This disorder primarily affects glucose metabolism and does not typically present with hepatosplenomegaly or bony pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Hexosaminidase A: </strong>Hexosaminidase A deficiency is associated with Tay-Sachs disease, which primarily affects the nervous system and does not typically present with hepatosplenomegaly or bony pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Beta-Galactosidase: </strong>Deficiency of Beta-Galactosidase is associated with GM1 gangliosidosis. This lysosomal storage disorder primarily affects the nervous system and is not typically associated with hepatosplenomegaly or bony pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gluco-Cerebrosidase, is associated with Gaucher's disease, a rare inherited metabolic disorder characterized by the accumulation of harmful quantities of glucosylceramide due to the deficiency of the enzyme glucocerebrosidase. Gaucher's disease can lead to the symptoms described, including hepatosplenomegaly, anemia, and bony pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>-Harper 31<sup>st</sup> e/pg. 235</strong></span></p>",
      "correct_choice_id": 19695,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9857,
      "choices": [
        {
          "id": 39394,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 39395,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency</span></p>"
        },
        {
          "id": 39396,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 39397,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoalbuminemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old female with easy fatiguability and pallor presented to the OPD. The image of her hand is as given below. What is the most likely diagnosis? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/987.jpg\" alt=\"\" width=\"300\" height=\"155\"></span></p>",
      "unique_key": "Q4025693",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137455,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin B12 deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Knuckle pigmentation is an easily visible and early sign of vitamin B12 deficiency due to increase in tyrosinase activity. It may occur even before the development of hematological and neurological complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In megaloblastic anemia, there is <strong>impairment of DNA synthesis</strong> that leads to ineffective hematopoiesis. It also causes distinctive morphologic changes, including abnormally large erythroid precursors and red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aplastic anemia</strong>: This condition involves pancytopenia and hypocellular bone marrow but does not typically present with knuckle pigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iron deficiency anemia</strong>: Iron deficiency anemia usually presents with pallor and fatigue but is not associated with knuckle pigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypoalbuminemia</strong>: Hypoalbuminemia may cause edema and other systemic symptoms but is not associated with knuckle pigmentation or anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Knuckle pigmentation is an early and visible sign of vitamin B12 deficiency, which can precede the more severe hematological and neurological complications associated with megaloblastic anemia.</span></p>",
      "correct_choice_id": 39395,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23233,
      "choices": [
        {
          "id": 92896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABO incompatibility </span></span></span></p>"
        },
        {
          "id": 92897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 </span></span></span></p>"
        },
        {
          "id": 92898,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosomal defect </span></span></span></p>"
        },
        {
          "id": 92899,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha thalassemia major</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the subsequent factors can lead to non-immune hydrops except for:&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q5087126",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137459,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) ABO incompatibility </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-immune hydrops refers to fetal hydrops that occur due to causes other than those related to maternal-fetal blood group incompatibility. ABO incompatibility is an immune-related cause of hydrops, known as immune hydrops, where the mother&#39;s immune system attacks the fetus&#39;s red blood cells due to incompatible ABO blood types. Non-immune hydrops arises from various other causes such as cardiovascular issues, genetic disorders, congenital infections, hematologic disorders, placental problems, and miscellaneous conditions. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Parvovirus B19</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a viral infection that can cause non-immune hydrops by affecting the fetus&#39;s red blood cells, leading to severe anemia and hydrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chromosomal defect</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chromosomal abnormalities, such as trisomy 21, 18, or 13, can cause non-immune hydrops through associated congenital abnormalities or malformations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Alpha thalassemia major</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a hematologic disorder that results in severe anemia, which can lead to non-immune hydrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABO incompatibility leads to immune hydrops and is not a cause of non-immune hydrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-105104.png\" style=\"height:990px; width:1000px\" /></p>",
      "correct_choice_id": 92896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32311,
      "choices": [
        {
          "id": 129098,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased telomere length with ageing</span></p>"
        },
        {
          "id": 129099,
          "text": "<p><span style=\"font-size:12.0pt;\">Gradually decreasing length of telomeres with ageing</span></p>"
        },
        {
          "id": 129100,
          "text": "<p><span style=\"font-size:12.0pt;\">Telomeres have coding sequences</span></p>"
        },
        {
          "id": 129101,
          "text": "<p><span style=\"font-size:12.0pt;\">Telomerase is found in somatic cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about telomeres and telomerase is:(NEET PG 2022)</span></p>",
      "unique_key": "Q1686444",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136797,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gradually decreasing length of telomeres with ageing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This statement is correct. Telomeres naturally shorten with each cell division, and this gradual shortening is associated with the aging process. It's a result of the end replication problem, where the DNA replication machinery cannot fully replicate the ends of linear chromosomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Increased telomere length with ageing:&nbsp;</strong>This statement is incorrect. Telomeres, the protective caps at the ends of chromosomes, tend to shorten with each cell division and are associated with aging. Over time, this can contribute to cellular senescence and aging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Telomeres have coding sequences:&nbsp;</strong>This statement is incorrect. Telomeres do not contain coding sequences for proteins. Instead, they consist of repetitive DNA sequences that provide a buffer zone to protect the essential genetic information during cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Telomerase is found in somatic cells</strong>: This statement is generally incorrect. Telomerase, the enzyme that can counteract telomere shortening by adding repetitive DNA sequences, is typically more active in germ cells and certain stem cells. In most somatic cells, telomerase activity is low, contributing to the progressive shortening of telomeres with each cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Telomeres are end of chromosomes and do not contain any coding sequences. Instead it has TTAGGG sequence repeated ‘n’ no. of times.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Telomerase is enzyme present only in the germ/stem cells and is responsible for maintaining the length of telomeres due to its RNA dependent DNA polymerase activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Somatic cells, absence of telomerase enzyme (option d is false) results in telomere shortening as the cells ages<strong>.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 355, 716</strong></span></p>",
      "correct_choice_id": 129099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10026,
      "choices": [
        {
          "id": 40070,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet</span></p>"
        },
        {
          "id": 40071,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrinsic</span></p>"
        },
        {
          "id": 40072,
          "text": "<p><span style=\"font-size:12.0pt;\">Extrinsic</span></p>"
        },
        {
          "id": 40073,
          "text": "<p><span style=\"font-size:12.0pt;\">vWD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following represents maximum amplitude in Thromboelastography? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4995419",
      "question_audio": null,
      "question_video": null,
      "map_id": 33137437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelet</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thromboelastography (TEG) is a test that measures the viscoelastic properties of blood as it clots under low shear conditions, mimicking sluggish venous flow. The <strong>maximum amplitude (MA)</strong> on a TEG tracing represents the final strength of the clot and is predominantly determined by the number and function of platelets and fibrin interaction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Platelets</strong> play a crucial role in forming the solid clot structure, which is reflected by the MA. Thus, the maximum amplitude in TEG is directly associated with platelet function and quantity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture3.jpg\" alt=\"\" width=\"250\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture4.jpg\" alt=\"\" width=\"500\" height=\"225\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Intrinsic and&nbsp;Option C.&nbsp;Extrinsic</strong>: These terms refer to different pathways of the coagulation cascade, not directly to the maximum amplitude in TEG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;vWD</strong>: von Willebrand Disease affects platelet adhesion due to deficiency or dysfunction of von Willebrand factor, but the maximum amplitude is a function of platelet interaction with fibrin, not directly of vWD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum amplitude in Thromboelastography represents platelets. TEG is a non-invasive test that quantitatively measures the ability of whole blood to form a clot.</span></p>",
      "correct_choice_id": 40070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5049,
      "choices": [
        {
          "id": 20170,
          "text": "<p><span style=\"font-size:12.0pt;\">Myophosphorylase</span></p>"
        },
        {
          "id": 20171,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphatase</span></p>"
        },
        {
          "id": 20172,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycogen synthase&nbsp;</span></p>"
        },
        {
          "id": 20173,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexokinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Enzyme defect in McArdle’s Disease?(NEET PG 2022)</span></p>",
      "unique_key": "Q3112551",
      "question_audio": null,
      "question_video": null,
      "map_id": 33136791,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Myophosphorylase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct answer. McArdle's Disease results from a deficiency of myophosphorylase, which is an enzyme responsible for breaking down glycogen into glucose within muscle cells. The lack of myophosphorylase impairs the ability of muscle cells to release glucose from glycogen during physical activity, leading to muscle fatigue, pain, and other symptoms typically observed in McArdle's Disease patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Glucose-6-phosphatase:&nbsp;</strong>This enzyme is involved in glucose metabolism in the liver, not in muscle cells. Deficiencies in glucose-6-phosphatase lead to other types of Glycogen Storage Diseases, such as Von Gierke's Disease (GSD Ia).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Glycogen synthase :&nbsp;</strong>While this enzyme plays a role in glycogen metabolism, it is not the enzyme affected in McArdle's Disease. Instead, it is myophosphorylase that is deficient in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Hexokinase:&nbsp;</strong>Hexokinase is involved in the initial steps of glucose metabolism but is not directly related to glycogen breakdown or McArdle's Disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">McArdle's disease&nbsp;is Type V glycogen storage disease that occurs due to deficiency of&nbsp;muscle glycogen phosphorylase (Myophosphorylase) enzyme. In this disease, muscle glycogen cannot be used during exercise, so, on strenuous exercise there are muscles cramps. Also, normal or relatively low levels of lactate will be formed from muscle glycogen after exercise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 167</strong></span></p>",
      "correct_choice_id": 20170,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}